{
    "paper_id": "PMC7111738",
    "metadata": {
        "title": "La maladie de Parkinson est-elle une maladie \u00e0 prion\u00a0?",
        "authors": [
            {
                "first": "J.-P.",
                "middle": [],
                "last": "Brandel",
                "suffix": "",
                "email": "jean-philippe.brandel@aphp.fr",
                "affiliation": {}
            },
            {
                "first": "A.-G.",
                "middle": [],
                "last": "Corbill\u00e9",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "P.",
                "middle": [],
                "last": "Derkinderen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "S.",
                "middle": [],
                "last": "Ha\u00efk",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "L\u2019hypoth\u00e8se de la nature exclusivement prot\u00e9ique des agents transmissibles non conventionnels (ATNC) a \u00e9t\u00e9 \u00e9mise \u00e0 la fin des ann\u00e9es 1960 sur la base des propri\u00e9t\u00e9s physico-chimiques exceptionnelles de ces agents [1], [2]. Le terme prion a \u00e9t\u00e9 cr\u00e9\u00e9 par Stanley Prusiner en 1982 pour qualifier l\u2019agent responsable de la transmission de la scrapie et des enc\u00e9phalopathies subaigu\u00ebs spongiformes transmissibles (ESST) [3]. Par d\u00e9finition, les prions sont des particules prot\u00e9iques infectieuses de petites tailles (\u00ab proteinaceous infectious particle \u00bb), r\u00e9sistantes aux proc\u00e9d\u00e9s d\u2019inactivation efficaces pour modifier les acides nucl\u00e9iques. Le terme prion souligne qu\u2019une prot\u00e9ine d\u00e9pourvue d\u2019acide nucl\u00e9ique est n\u00e9cessaire et suffisante \u00e0 \u00ab l\u2019infection \u00bb. Si les maladies \u00e0 prions entrent bien dans la d\u00e9finition des maladies infectieuses propos\u00e9e par l\u2019OMS (\u00ab Les maladies infectieuses sont caus\u00e9es par des microorganismes pathog\u00e8nes, tels que les bact\u00e9ries, les virus, les parasites ou les champignons. Ces maladies peuvent se transmettre, directement ou indirectement, d\u2019une personne \u00e0 l\u2019autre \u00bb) (http://www.who.int/topics/infectious_diseases/fr/il), il faut souligner que, chez l\u2019homme et contrairement \u00e0 certaines maladies animales comme la maladie du d\u00e9p\u00e9rissement chronique des cervid\u00e9s, elles ne sont pas contagieuses. Les rares cas de transmission interhumaine, depuis la disparition du kuru, r\u00e9sultent de contaminations accidentelles en r\u00e8gle iatrog\u00e8ne [4]. Un prion est donc un agent transmissible accidentellement ou exp\u00e9rimentalement dont l\u2019infectivit\u00e9 peut \u00eatre titr\u00e9e. Il faut bien les distinguer de ce qui a \u00e9t\u00e9 appel\u00e9 par facilit\u00e9 de langage \u00ab prions de levure \u00bb ou \u00ab prions physiologiques \u00bb en r\u00e9f\u00e9rence au m\u00e9canisme mol\u00e9culaire gouvernant la r\u00e9plication de ces agents et aux propri\u00e9t\u00e9s de la prot\u00e9ine prion.",
            "cite_spans": [
                {
                    "start": 213,
                    "end": 216,
                    "mention": "[1]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 218,
                    "end": 221,
                    "mention": "[2]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 415,
                    "end": 418,
                    "mention": "[3]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1462,
                    "end": 1465,
                    "mention": "[4]",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Qu\u2019est-ce qu\u2019un prion\u00a0? ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "En effet, la prot\u00e9ine prion a pour principales caract\u00e9ristiques :\u2022d\u2019exister sous diff\u00e9rentes conformations, une forme normale dont la structure secondaire est riche en h\u00e9lice \u03b1 et une forme agr\u00e9g\u00e9e enrichie en feuillets \u03b2 qui peut exister sous la forme d\u2019oligom\u00e8res ou de fibrilles et qui s\u2019accumule en cas de pathologie ;\u2022de pouvoir initier, sous sa forme pathologique, l\u2019agr\u00e9gation et le mauvais repliement de la forme normale de la prot\u00e9ine (\u00ab seeding \u00bb) ;\u2022de pouvoir \u00eatre transf\u00e9r\u00e9e de cellules \u00e0 cellules sous sa forme agr\u00e9g\u00e9e, in vitro et in vivo, et d\u2019induire dans la cellule ou le tissu h\u00f4te le processus de conversion (\u00ab spreading \u00bb).\n",
            "cite_spans": [],
            "section": "Qu\u2019est-ce qu\u2019un prion\u00a0? ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Dans le cas des prions de mammif\u00e8res, ces ph\u00e9nom\u00e8nes sont associ\u00e9s au d\u00e9clenchement d\u2019une ESST.",
            "cite_spans": [],
            "section": "Qu\u2019est-ce qu\u2019un prion\u00a0? ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Le terme de prion a \u00e9t\u00e9 utilis\u00e9 par la suite pour nommer des ph\u00e9nom\u00e8nes biologiques tr\u00e8s diff\u00e9rents et bien distincts des \u00ab proteinaceous infectious particle \u00bb dont le point commun est la mise en jeu de prot\u00e9ines sp\u00e9cifiques partageant les caract\u00e9ristiques de la prot\u00e9ine prion (deux conformations, initiation et diss\u00e9mination d\u2019un processus transconformationnel). \u00c0 titre d\u2019exemple, les \u00ab prions \u00bb de levure mettent en jeu des prot\u00e9ines notamment impliqu\u00e9es dans l\u2019adaptation de ces organismes \u00e0 leur environnement [5] ; l\u2019agr\u00e9gation auto-entretenue d\u2019un facteur de traduction appel\u00e9 CPEB, pour cytoplasmic polyadenylation element binding protein, interviendrait dans le m\u00e9canisme physiologique de maintien de la m\u00e9moire \u00e0 long terme [6]. Du fait de ce glissement s\u00e9mantique, le terme de prion recouvre donc deux ph\u00e9nom\u00e8nes bien distincts : un m\u00e9canisme biochimique de transmission d\u2019une information biologique, d\u2019une part, (m\u00e9canisme de type prion, prot\u00e9ine de type prion, prions de levure, prions physiologiques, etc.) ; un agent transmissible responsable d\u2019une enc\u00e9phalopathie chez l\u2019homme et l\u2019animal d\u2019autre part. Si les concepts m\u00e9canistiques et infectieux sont bien associ\u00e9s dans le cas des maladies \u00e0 prions, il semble clair que cela ne vaut pas dans tout ph\u00e9nom\u00e8ne biologique o\u00f9 ces modifications conformationnelles sont observ\u00e9es.",
            "cite_spans": [
                {
                    "start": 516,
                    "end": 519,
                    "mention": "[5]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 735,
                    "end": 738,
                    "mention": "[6]",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Qu\u2019est-ce qu\u2019un prion\u00a0? ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "La forme normale de la prot\u00e9ine prion (PrP) est la prot\u00e9ine PrPc dont la structure primaire comprend, chez l\u2019homme, 253 acides amin\u00e9s avec un poids mol\u00e9culaire qui varie de 33 \u00e0 35 kDa selon le niveau de glycosylation. Sa structure secondaire est constitu\u00e9e d\u2019un taux \u00e9lev\u00e9 d\u2019h\u00e9lices \u03b1 (42 %) et de peu de feuillets \u03b2 (3 %). Sa structure tridimensionnelle a \u00e9t\u00e9 \u00e9tablie par r\u00e9sonance magn\u00e9tique nucl\u00e9aire sur des prot\u00e9ines recombinantes [7]. Elle se compose d\u2019une partie N-terminale, des acides amin\u00e9s 23 \u00e0 121, qui a une structure tr\u00e8s flexible pouvant adopter plusieurs conformations en fonction de l\u2019environnement, d\u2019une structure globulaire stable contenant 3 h\u00e9lices \u03b1 au niveau des acides amin\u00e9s 144\u2013154 ; 175\u2013193 ; 200\u2013219 et 2 courts feuillets \u03b2 antiparall\u00e8les au niveau 128\u2013131 ; 161\u2013164 et d\u2019une partie C-terminale poss\u00e9dant une ancre GPI permettant d\u2019arrimer la PrP au feuillet externe de la membrane cellulaire. Si le r\u00f4le physiologique jou\u00e9 par la PrP cellulaire reste d\u00e9battu, elle s\u2019av\u00e8re indispensable au d\u00e9veloppement de la maladie puisque les animaux dont le g\u00e8ne de la PrP a \u00e9t\u00e9 invalid\u00e9 (animaux \u00ab knockout \u00bb ou KO) ne sont pas susceptibles aux ATNC [8]. Son niveau d\u2019expression a un r\u00f4le d\u00e9terminant dans la dur\u00e9e de la p\u00e9riode d\u2019incubation qui est d\u2019autant plus courte que le niveau d\u2019expression est \u00e9lev\u00e9. Enfin certains polymorphismes du g\u00e8ne PRNP codant la PrP et surtout le polymorphisme m\u00e9thionine/valine au codon 129 jouent un r\u00f4le important dans la susceptibilit\u00e9 individuelle aux ESST. L\u2019homologie de s\u00e9quence entre la PrPsc de l\u2019inoculum et la PrPc de l\u2019h\u00f4te d\u00e9termine en partie la barri\u00e8re d\u2019esp\u00e8ce lors d\u2019une transmission intersp\u00e9cifique. Ainsi les souris sont r\u00e9sistantes aux souches de hamster sauf si l\u2019on introduit dans leur g\u00e9nome une PrPc de hamster [9]. Ceci est vrai aussi pour les souches humaines dont la transmission n\u00e9cessite en plus de l\u2019introduction du g\u00e8ne humain l\u2019invalidation du g\u00e8ne de la PrP murine. Dans certains mod\u00e8les, l\u2019expression d\u2019une prot\u00e9ine PrP chim\u00e8re dont les extr\u00e9mit\u00e9s portent les s\u00e9quences murines et le domaine central une s\u00e9quence humaine facilite la transmission des souches humaines, particularit\u00e9 expliqu\u00e9e par l\u2019action de cofacteurs associ\u00e9s sp\u00e9cifiques d\u2019esp\u00e8ce encore non d\u00e9termin\u00e9s (prot\u00e9ine X) [10].",
            "cite_spans": [
                {
                    "start": 437,
                    "end": 440,
                    "mention": "[7]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1170,
                    "end": 1173,
                    "mention": "[8]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 1789,
                    "end": 1792,
                    "mention": "[9]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 2272,
                    "end": 2276,
                    "mention": "[10]",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "PrPc et PrPsc ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "La forme pathologique de la PrP, la PrPsc (pour PrP scrapie) a la m\u00eame structure primaire que la PrPc\n[11]. La digestion par la prot\u00e9inase K utilis\u00e9e lors de la purification de la prot\u00e9ine conduit \u00e0 l\u2019\u00e9limination de la portion N-terminale de la PrP g\u00e9n\u00e9rant une forme de 27 \u00e0 30 kDa. Comme la PrPc, la PrPsc poss\u00e8de une ancre GPI, et son profil de glycosylation est identique \u00e0 celui de la PrPc. L\u2019analyse de la structure secondaire de la PrPsc, bien qu\u2019incompl\u00e8te, a r\u00e9v\u00e9l\u00e9 d\u2019importantes diff\u00e9rences avec celle de la PrP cellulaire, sugg\u00e9rant un enrichissement marqu\u00e9 en feuillets \u03b2 pliss\u00e9es [12], [13]. \u00c0 ce jour, en raison des propri\u00e9t\u00e9s physico-chimiques de la PrPsc (pouvoir d\u2019agr\u00e9gation, insolubilit\u00e9 dans les d\u00e9tergents), aucune structure tertiaire n\u2019a \u00e9t\u00e9 obtenue par r\u00e9sonance magn\u00e9tique ou par cristallographie aux rayons X. Les seules structures disponibles ont \u00e9t\u00e9 \u00e9tablies par mod\u00e9lisation mol\u00e9culaire.",
            "cite_spans": [
                {
                    "start": 102,
                    "end": 106,
                    "mention": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 593,
                    "end": 597,
                    "mention": "[12]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 599,
                    "end": 603,
                    "mention": "[13]",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "PrPc et PrPsc ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Les ATNC poss\u00e8dent des propri\u00e9t\u00e9s peu communes de r\u00e9sistance aux proc\u00e9d\u00e9s habituels d\u2019inactivation des agents microbiologiques. Les ultrasons, les rayonnements ionisants et non ionisants, les nucl\u00e9ases, le formald\u00e9hyde et les d\u00e9tergents sont peu efficaces, voire totalement inefficaces. Par ailleurs, ces agents pr\u00e9sentent une forte r\u00e9sistance \u00e0 l\u2019inactivation par la chaleur s\u00e8che. De mani\u00e8re g\u00e9n\u00e9rale, l\u2019infectivit\u00e9 r\u00e9siste bien mieux aux proc\u00e9d\u00e9s d\u00e9truisant les acides nucl\u00e9iques qu\u2019aux proc\u00e9d\u00e9s d\u00e9gradant ou d\u00e9naturant les prot\u00e9ines ; ainsi, les ions chaotropes, le ph\u00e9nol ou les digestions par des prot\u00e9ases diminuent sensiblement le titre infectieux.",
            "cite_spans": [],
            "section": "PrPc et PrPsc ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "La r\u00e9plication des prions reposerait sur un m\u00e9canisme de conversion prot\u00e9ique dans lequel la pr\u00e9sence d\u2019une forme pathologique, en r\u00e8gle agr\u00e9g\u00e9e et riche en feuillets \u03b2-pliss\u00e9s, d\u2019une prot\u00e9ine d\u00e9clenche l\u2019agr\u00e9gation de la forme normale qui devient \u00e0 son tour capable de promouvoir le recrutement et la polym\u00e9risation de la prot\u00e9ine normale [14]. Plusieurs mod\u00e8les en ont \u00e9t\u00e9 propos\u00e9s, notamment :\u2022le mod\u00e8le de conversion (ou polym\u00e9risation) assist\u00e9 par une amorce dans lequel la PrPsc serait plus stable que la PrPc mais cin\u00e9tiquement inaccessible, la conversion passerait par un interm\u00e9diaire conformationnel \u00e9quidistant thermodynamiquement de la PrPc et de la PrPsc, la liaison entre la PrPsc et cet interm\u00e9diaire favoriserait sa conversion en PrPsc (Fig. 1\nA) ;\u2022le mod\u00e8le de nucl\u00e9ation-polym\u00e9risation dans lequel la transconformation de la PrPc en PrPsc monom\u00e9rique serait r\u00e9versible, la PrPsc \u00e9tant moins stable que la PrPc la pr\u00e9sence d\u2019agr\u00e9gats d\u00e9pla\u00e7ant l\u2019\u00e9quilibre vers la formation de PrPsc\n[15], [16]. La liaison entre la PrPsc et cet interm\u00e9diaire favoriserait sa conversion en PrPsc (Fig. 1B).\n",
            "cite_spans": [
                {
                    "start": 340,
                    "end": 344,
                    "mention": "[14]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1000,
                    "end": 1004,
                    "mention": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1006,
                    "end": 1010,
                    "mention": "[16]",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Avanc\u00e9es r\u00e9centes en faveur de l\u2019hypoth\u00e8se du prion ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": [
                {
                    "start": 753,
                    "end": 759,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1096,
                    "end": 1102,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Dans ces mod\u00e8les, une conversion spontan\u00e9e, ph\u00e9nom\u00e8ne al\u00e9atoire et rare possiblement li\u00e9 \u00e0 une mutation somatique, conduirait \u00e0 une forme sporadique. Dans les formes g\u00e9n\u00e9tiques, la pr\u00e9sence d\u2019une mutation augmenterait la probabilit\u00e9 de l\u2019\u00e9v\u00e9nement de conversion. Dans les formes infectieuses, l\u2019introduction de PrPsc dans un organisme h\u00f4te conduirait dans certaines conditions au recrutement et \u00e0 la conversion de la PrPc endog\u00e8ne. La diss\u00e9mination de cette anomalie conformationnelle serait assur\u00e9e par la capacit\u00e9 qu\u2019ont ces structures agr\u00e9g\u00e9es \u00e0 passer d\u2019une cellule \u00e0 l\u2019autre (\u00ab spreading \u00bb) selon des m\u00e9canismes non compl\u00e8tement \u00e9lucid\u00e9s \u00e0 ce jour (exocytose/endocytose, exosomes, nanotubes\u2026). Apr\u00e8s avoir atteint leurs cellules cibles, les noyaux d\u2019agr\u00e9gation gardent leur activit\u00e9 et sont capables de recruter et de convertir la prot\u00e9ine de l\u2019h\u00f4te.",
            "cite_spans": [],
            "section": "Avanc\u00e9es r\u00e9centes en faveur de l\u2019hypoth\u00e8se du prion ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "La d\u00e9monstration de la validit\u00e9 du mod\u00e8le du prion passe par la production, \u00e0 partir de PrPc, de PrPsc infectieuse dans un syst\u00e8me exp\u00e9rimental contr\u00f4l\u00e9. Diff\u00e9rentes approches ont \u00e9t\u00e9 tent\u00e9es dans le but de d\u00e9montrer l\u2019hypoth\u00e8se du prion. Elles ont permis d\u2019apporter des arguments en sa faveur et de valider l\u2019hypoth\u00e8se d\u2019une conversion PrPsc-d\u00e9pendante de la PrPc en PrP prot\u00e9inase K r\u00e9sistante.",
            "cite_spans": [],
            "section": "Avanc\u00e9es r\u00e9centes en faveur de l\u2019hypoth\u00e8se du prion ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Tr\u00e8s r\u00e9cemment, quatre avanc\u00e9es majeures ont apport\u00e9 des arguments presque d\u00e9finitifs en faveur de l\u2019hypoth\u00e8se du prion, elles doivent tout de m\u00eame \u00eatre confirm\u00e9es :\u2022le groupe de Susan Lindquist au MIT a mis \u00e0 profit la technique de la mutagen\u00e8se dirig\u00e9e pour produire des lign\u00e9es murines exprimant une PrP humaine D178N-M129 ou une PrP E200K. Alors que la lign\u00e9e D178-M129 d\u00e9veloppait un ph\u00e9notype clinico-pathologique tr\u00e8s proche de l\u2019IFF (insomnie, troubles neurov\u00e9g\u00e9tatifs et atrophie thalamique), les souris E200K pr\u00e9sentaient une maladie proche de la MCJ [17], [18]. Les deux maladies \u00e9taient transmissibles et conservaient leurs caract\u00e9ristiques lors des passages successifs ;\u2022des \u00e9quipes ind\u00e9pendantes ont montr\u00e9 que l\u2019amplification de la PrPsc issue d\u2019un sujet atteint et produite dans un tube \u00e0 essai par la technique de Protein Misfolding Cyclic Amplification (PMCA) s\u2019accompagnait d\u2019une amplification de l\u2019infectiosit\u00e9 [19], [20] ;\u2022des agents infectieux ont pu \u00eatre produits par la m\u00e9thode de PMCA en utilisant des composants \u00ab prion-free \u00bb tr\u00e8s simple : PrPc extraite de cerveau normal, poly-A, lipides ou PrP recombinante produite dans E. coli, ARN totaux extraits du foie de souris saine, lipide de synth\u00e8se [21], [22] ;\u2022le groupe de Stanley Prusiner a pu produire un prion synth\u00e9tique en modifiant la conformation et l\u2019\u00e9tat d\u2019agr\u00e9gation d\u2019une PrP recombinante tronqu\u00e9e [23], [24].\n",
            "cite_spans": [
                {
                    "start": 561,
                    "end": 565,
                    "mention": "[17]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 567,
                    "end": 571,
                    "mention": "[18]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 931,
                    "end": 935,
                    "mention": "[19]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 937,
                    "end": 941,
                    "mention": "[20]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1223,
                    "end": 1227,
                    "mention": "[21]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1229,
                    "end": 1233,
                    "mention": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1385,
                    "end": 1389,
                    "mention": "[23]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1391,
                    "end": 1395,
                    "mention": "[24]",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Avanc\u00e9es r\u00e9centes en faveur de l\u2019hypoth\u00e8se du prion ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Une diversit\u00e9 de souches a pu \u00eatre mise en \u00e9vidence par des exp\u00e9riences de transmission dans des lign\u00e9es de souris ayant le m\u00eame fond g\u00e9n\u00e9tique. En pratique, pour une m\u00eame dose infectante inocul\u00e9e selon une voie donn\u00e9e, chaque souche d\u2019agent induit chez des souris syng\u00e9niques, une maladie caract\u00e9ris\u00e9e par :\u2022un temps d\u2019incubation bien d\u00e9termin\u00e9 ;\u2022un profil l\u00e9sionnel caract\u00e9ristique dont les crit\u00e8res sont les sites d\u2019accumulation dans le syst\u00e8me nerveux central (SNC) de la PrPsc et de la spongiose.\n",
            "cite_spans": [],
            "section": "Ph\u00e9nom\u00e8ne de souches ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Les caract\u00e9ristiques d\u2019une souche ne s\u2019\u00e9tablissent qu\u2019apr\u00e8s 2 \u00e0 3 passages s\u00e9ri\u00e9s : le temps d\u2019incubation diminue pour se stabiliser et les profils l\u00e9sionnels deviennent constants. On dit alors que la souche est \u00ab stabilis\u00e9e \u00bb. Plus d\u2019une vingtaine de souches diff\u00e9rentes ont \u00e9t\u00e9 ainsi isol\u00e9es \u00e0 partir d\u2019ESST naturelles (tremblante du mouton, de la ch\u00e8vre, enc\u00e9phalopathie spongiforme bovine\u2026). Le support mol\u00e9culaire de la diversit\u00e9 des souches de prions reposerait sur la capacit\u00e9 de la PrP \u00e0 adopter des conformations et \u00e0 former des assemblages diff\u00e9rents [25], [26].",
            "cite_spans": [
                {
                    "start": 561,
                    "end": 565,
                    "mention": "[25]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 567,
                    "end": 571,
                    "mention": "[26]",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Ph\u00e9nom\u00e8ne de souches ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "Dans le cas d\u2019une contamination par voie p\u00e9riph\u00e9rique (voie orale ou intrap\u00e9riton\u00e9ale par exemple), une \u00e9tape de r\u00e9plication dans les tissus lympho\u00efdes est n\u00e9cessaire \u00e0 la neuroinvasion. Chez l\u2019homme, ce ph\u00e9nom\u00e8ne a \u00e9t\u00e9 particuli\u00e8rement bien mis en \u00e9vidence dans la variante de la MCJ. L\u2019agent est trouv\u00e9 dans les structures lympho\u00efdes, notamment celles associ\u00e9es au tube digestif, au sein des cellules folliculaires dendritiques des follicules \u00e0 centres clairs [27]. Il utilise ensuite l\u2019abondante innervation sympathique de ces tissus pour gagner, via les ganglions c\u0153liaques et stellaires, la m\u0153lle \u00e9pini\u00e8re pour ensuite se propager \u00e0 l\u2019ensemble du SNC [28], [29]. Une prion\u00e9mie est \u00e9galement associ\u00e9e \u00e0 cette forme et quelques cas post-transfusionnels ont \u00e9t\u00e9 observ\u00e9s au Royaume-Uni [30], [31].",
            "cite_spans": [
                {
                    "start": 462,
                    "end": 466,
                    "mention": "[27]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 656,
                    "end": 660,
                    "mention": "[28]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 662,
                    "end": 666,
                    "mention": "[29]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 788,
                    "end": 792,
                    "mention": "[30]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 794,
                    "end": 798,
                    "mention": "[31]",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Propagation p\u00e9riph\u00e9rique dans les maladies \u00e0 prions ::: Les maladies \u00e0 prions, paradigme des maladies conformationnelles des prot\u00e9ines du syst\u00e8me nerveux central",
            "ref_spans": []
        },
        {
            "text": "L\u2019\u03b1-synucl\u00e9ine a \u00e9t\u00e9 isol\u00e9e et s\u00e9quenc\u00e9e \u00e0 partir de l\u2019organe \u00e9lectrique du poisson torpille en 1988. Dans sa description initiale, l\u2019\u00e9quipe de Richard Scheller a montr\u00e9 que cette prot\u00e9ine neuronale de 143 acides amin\u00e9s \u00e9tait localis\u00e9e dans les terminaisons synaptiques et dans le noyau, d\u2019o\u00f9 son nom (\u00ab syn \u00bb pour synapse et \u00ab nuclein \u00bb pour noyau) [32]. Une prot\u00e9ine homologue de 140 acides amin\u00e9s a ensuite \u00e9t\u00e9 identifi\u00e9e dans le SNC du rat et de l\u2019homme [33]. Cette d\u00e9couverte de l\u2019\u03b1-synucl\u00e9ine n\u2019a re\u00e7u initialement que peu d\u2019\u00e9cho. Il a fallu attendre la deuxi\u00e8me partie des ann\u00e9es 1990 et l\u2019identification d\u2019une mutation du g\u00e8ne codant l\u2019\u03b1-synucl\u00e9ine, dans une famille avec une maladie de Parkinson de transmission autosomique dominante, pour que l\u2019\u03b1-synucl\u00e9ine passe sur le devant de la sc\u00e8ne [34]. Quelques mois apr\u00e8s la mise en \u00e9vidence de cette premi\u00e8re forme monog\u00e9nique de maladie de Parkinson, une \u00e9quipe de Cambridge a montr\u00e9 que les corps et prolongements de Lewy de patients atteints de formes sporadiques de la maladie \u00e9taient fortement immunor\u00e9actifs pour l\u2019\u03b1 -synucl\u00e9ine et qu\u2019elle \u00e9tait donc un des principaux composants de la pathologie de Lewy [35]. En 2002, Fujiwara et al. ont par ailleurs montr\u00e9 que l\u2019\u03b1-synucl\u00e9ine pr\u00e9sente dans les corps et prolongements de Lewy \u00e9tait non seulement agr\u00e9g\u00e9e mais aussi phosphoryl\u00e9e sur un r\u00e9sidu s\u00e9rine (S\u00e9rine 129) [36]. L\u2019immunohistochimie de l\u2019\u03b1-synucl\u00e9ine et de la phospho-\u03b1-synucl\u00e9ine est depuis lors devenue la technique de r\u00e9f\u00e9rence pour la mise en \u00e9vidence des corps et prolongements de Lewy, cette approche \u00e9tant plus sensible que les techniques qui \u00e9taient utilis\u00e9es auparavant qu\u2019elles soient histochimiques (marquage h\u00e9matine/\u00e9osine) ou immunohistochimiques (anticorps anti-ubiquitine) [37]. Cette technique a permis une analyse plus pr\u00e9cise de la distribution de la pathologie de Lewy. Elle a en effet montr\u00e9 qu\u2019en dehors de la substance noire, certaines structures du SNC comme le bulbe olfactif et le noyau dorsal moteur du vague et des syst\u00e8mes nerveux autonomes p\u00e9riph\u00e9riques comme le syst\u00e8me nerveux ent\u00e9rique (SNE) sont touch\u00e9es par le processus pathologique chez la quasi-totalit\u00e9 des patients parkinsoniens [38], [39].",
            "cite_spans": [
                {
                    "start": 350,
                    "end": 354,
                    "mention": "[32]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 458,
                    "end": 462,
                    "mention": "[33]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 800,
                    "end": 804,
                    "mention": "[34]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 1166,
                    "end": 1170,
                    "mention": "[35]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1375,
                    "end": 1379,
                    "mention": "[36]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1757,
                    "end": 1761,
                    "mention": "[37]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 2187,
                    "end": 2191,
                    "mention": "[38]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 2193,
                    "end": 2197,
                    "mention": "[39]",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "L\u2019\u03b1-synucl\u00e9ine, une prot\u00e9ine intracellulaire, composant majeur des corps de Lewy ::: L\u2019\u03b1-synucl\u00e9ine",
            "ref_spans": []
        },
        {
            "text": "Depuis 1997, de nombreux travaux se sont int\u00e9ress\u00e9s aux r\u00f4les physiologique et physiopathologique de l\u2019\u03b1-synucl\u00e9ine. L\u2019\u03b1-synucl\u00e9ine humaine est une petite prot\u00e9ine de 140 acides amin\u00e9s (14,5 kDa) divis\u00e9e d\u2019un point de vue fonctionnel en 3 domaines (Fig. 2\nA). La partie amino-terminale est fortement conserv\u00e9e entre les 3 isoformes de synucl\u00e9ine et est impliqu\u00e9e dans la liaison de l\u2019\u03b1-synucl\u00e9ine aux lipides et aux membranes cellulaires. Le domaine central joue un r\u00f4le essentiel dans les capacit\u00e9s d\u2019agr\u00e9gation de la prot\u00e9ine alors que l\u2019extr\u00e9mit\u00e9 carboxy-terminale serait responsable de l\u2019activit\u00e9 chaperonne et contient les principaux sites de phosphorylation. Bien que l\u2019\u03b1-synucl\u00e9ine pr\u00e9sente une conformation monom\u00e9rique en solution, elle a une capacit\u00e9 naturelle \u00e0 s\u2019agr\u00e9ger en structures amylo\u00efdes gr\u00e2ce \u00e0 son domaine central selon la progression suivante : dim\u00e8res, oligom\u00e8res, protofibrilles et fibrilles puis enfin corps de Lewy (Fig. 2B). L\u2019agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine est plus importante pour les formes tronqu\u00e9es de la prot\u00e9ine et pour les formes mut\u00e9es responsables de maladie de Parkinson g\u00e9n\u00e9tique. L\u2019introduction d\u2019oligom\u00e8res ou de protofibrilles pr\u00e9form\u00e9s dans des neurones en culture primaire ou in vivo provoque une agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine endog\u00e8ne, un ph\u00e9nom\u00e8ne appel\u00e9 \u00ab nucl\u00e9ation \u00bb (revue dans [40]).",
            "cite_spans": [
                {
                    "start": 1324,
                    "end": 1328,
                    "mention": "[40]",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "L\u2019\u03b1-synucl\u00e9ine, une prot\u00e9ine intracellulaire, composant majeur des corps de Lewy ::: L\u2019\u03b1-synucl\u00e9ine",
            "ref_spans": [
                {
                    "start": 249,
                    "end": 255,
                    "mention": "Fig. 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 941,
                    "end": 947,
                    "mention": "Fig. 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Bien que l\u2019\u03b1-synucl\u00e9ine ait longtemps \u00e9t\u00e9 consid\u00e9r\u00e9e comme une prot\u00e9ine purement intracellulaire, la pr\u00e9sence de la prot\u00e9ine dans le liquide c\u00e9phalo-rachidien et le plasma a logiquement conduit certains groupes \u00e0 \u00e9tudier si elle pouvait \u00eatre s\u00e9cr\u00e9t\u00e9e. Plusieurs \u00e9quipes ind\u00e9pendantes ont montr\u00e9 que l\u2019\u03b1-synucl\u00e9ine \u00e9tait en effet s\u00e9cr\u00e9t\u00e9e puisque mise en \u00e9vidence dans le milieu de culture de neurones du SNC ou du syst\u00e8me nerveux p\u00e9riph\u00e9rique [41], [42]. Cette s\u00e9cr\u00e9tion d\u2019\u03b1-synucl\u00e9ine se produit en condition physiologique mais est plus importante en conditions pathologiques par exemple lors d\u2019un stress oxydant, d\u2019une dysfonction mitochondriale ou du syst\u00e8me ubiquitine-prot\u00e9asome. Dans ces conditions pathologiques, l\u2019\u03b1-synucl\u00e9ine est essentiellement lib\u00e9r\u00e9e sous forme oligom\u00e9rique [43]. L\u2019\u03b1-synucl\u00e9ine serait s\u00e9cr\u00e9t\u00e9e par diff\u00e9rents m\u00e9canismes impliquant des m\u00e9canismes conventionnels ou non conventionnels d\u2019exocytose ainsi que la voie des exosomes [41], [42], [44]. Il est probable que les voies de s\u00e9cr\u00e9tion mises en jeu d\u00e9pendent du type de neurone impliqu\u00e9, p\u00e9riph\u00e9rique ou central.",
            "cite_spans": [
                {
                    "start": 443,
                    "end": 447,
                    "mention": "[41]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 449,
                    "end": 453,
                    "mention": "[42]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 787,
                    "end": 791,
                    "mention": "[43]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 956,
                    "end": 960,
                    "mention": "[41]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 962,
                    "end": 966,
                    "mention": "[42]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 968,
                    "end": 972,
                    "mention": "[44]",
                    "ref_id": "BIBREF44"
                }
            ],
            "section": "L\u2019\u03b1-synucl\u00e9ine est aussi une prot\u00e9ine extracellulaire ::: L\u2019\u03b1-synucl\u00e9ine",
            "ref_spans": []
        },
        {
            "text": "L\u2019observation de corps de Lewy (CL) et de neurites de Lewy (NL), dans certains neurones embryonnaires transplant\u00e9s 11 \u00e0 16 ans auparavant dans le striatum de patients parkinsoniens a \u00e9t\u00e9 le premier argument en faveur d\u2019une transmission de cellules \u00e0 cellules de d\u00e9p\u00f4ts constitu\u00e9s majoritairement d\u2019\u03b1-synucl\u00e9ine [45], [46]. En effet, la pr\u00e9sence de ces inclusions est anormale dans des neurones jeunes. Les inclusions sont constitu\u00e9es des m\u00eames \u00e9l\u00e9ments (\u03b1-synucl\u00e9ine fibrillaire phosphoryl\u00e9e en S\u00e9rine 129, ubiquitine) que les CL observ\u00e9s dans la substantia nigra des patients parkinsoniens [45]. Ces inclusions sont marqu\u00e9es par la thioflavine S indiquant la pr\u00e9sence de feuillets \u03b2. Il existe parall\u00e8lement une diminution du transporteur de la dopamine et de la tyrosine hydroxylase [46]. Cependant, l\u2019apparition des inclusions ne concerne pas tous les neurones chez un patient donn\u00e9 [45] et l\u2019analyse post-mortem du cerveau de patients greff\u00e9s 9 \u00e0 14 ans auparavant peut r\u00e9v\u00e9ler des neurones greff\u00e9s fonctionnels et sans inclusions pathologiques [47]. L\u2019\u00e9tude de Kurowska et al. a montr\u00e9 que les greffes les plus \u00e2g\u00e9es (plus de 20 ans) ont une expression r\u00e9duite de la tyrosine hydroxylase et du transporteur de la dopamine et une pathologie de Lewy plus marqu\u00e9e [48]. Une des hypoth\u00e8ses pouvant expliquer ces observations est celle d\u2019une propagation de l\u2019anomalie conformationnelle du tissu h\u00f4te vers le greffon \u00e0 la mani\u00e8re des prions. Prusiner et Olanow l\u2019ont formalis\u00e9 en proposant que la maladie de Parkinson pourrait \u00eatre une maladie \u00e0 prion [49], r\u00e9sultant directement d\u2019une augmentation de la production ou d\u2019une diminution de la clearance de l\u2019\u03b1-synucl\u00e9ine favorisant son repliement anormal et la formation d\u2019oligom\u00e8res neurotoxiques. L\u2019\u03b1-synucl\u00e9ine pourrait \u00eatre un analogue de la prot\u00e9ine prion capable d\u2019auto-agr\u00e9gation et de diss\u00e9mination \u00e0 des cellules saines.",
            "cite_spans": [
                {
                    "start": 311,
                    "end": 315,
                    "mention": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 317,
                    "end": 321,
                    "mention": "[46]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 591,
                    "end": 595,
                    "mention": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 785,
                    "end": 789,
                    "mention": "[46]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 886,
                    "end": 890,
                    "mention": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 1049,
                    "end": 1053,
                    "mention": "[47]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1266,
                    "end": 1270,
                    "mention": "[48]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 1551,
                    "end": 1555,
                    "mention": "[49]",
                    "ref_id": "BIBREF49"
                }
            ],
            "section": "Corps de Lewy dans des neurones embryonnaires transplant\u00e9s ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Les propri\u00e9t\u00e9s d\u2019agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine ont bien \u00e9t\u00e9 document\u00e9es in vitro. L\u2019\u03b1-synucl\u00e9ine monom\u00e9rique sauvage ou mut\u00e9e forme \u00e0 37 \u00b0C des fibrilles ayant des caract\u00e9ristiques similaires \u00e0 celles observ\u00e9es dans les CL [50], [51]. Bien qu\u2019elles aient la m\u00eame structure native, l\u2019\u03b1, la \u03b2- et la \u03b3-synucl\u00e9ine ont un pouvoir intrins\u00e8que de fibrillation diff\u00e9rent qui est nettement plus \u00e9lev\u00e9 pour l\u2019\u03b1-synucl\u00e9ine que pour les deux autres formes. Les fibrilles peuvent constituer une amorce (\u00ab seeds \u00bb) et acc\u00e9l\u00e9rer la formation de fibrilles \u00e0 partir d\u2019\u03b1-synucl\u00e9ine monom\u00e9rique. La mise en contact d\u2019\u03b1-synucl\u00e9ine monom\u00e9rique sauvage avec des fibrilles d\u2019\u03b1-synucl\u00e9ine porteuse de la mutation A30P entra\u00eene la formation de fibrilles porteuses des caract\u00e9ristiques associ\u00e9es \u00e0 la prot\u00e9ine A30P, argument en faveur d\u2019un changement de conformation de l\u2019\u03b1-synucl\u00e9ine sauvage [52].",
            "cite_spans": [
                {
                    "start": 222,
                    "end": 226,
                    "mention": "[50]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 228,
                    "end": 232,
                    "mention": "[51]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 867,
                    "end": 871,
                    "mention": "[52]",
                    "ref_id": "BIBREF52"
                }
            ],
            "section": "Exp\u00e9rimentations in vitro en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Les assemblages d\u2019\u03b1-synucl\u00e9ine peuvent \u00eatre transf\u00e9r\u00e9s de neurones \u00e0 neurones. Une co-culture de neurones sur-exprimant l\u2019\u03b1-synucl\u00e9ine et de neurones ne sur-exprimant pas l\u2019\u03b1-synucl\u00e9ine permet d\u2019obtenir au bout de 24 heures, la diffusion de l\u2019\u03b1-synucl\u00e9ine des premiers aux seconds avec formation d\u2019inclusions dans les neurones \u00ab receveurs \u00bb [53]. Un ph\u00e9nom\u00e8ne identique est observ\u00e9 en cas d\u2019incubation des neurones \u00ab receveurs \u00bb dans un milieu acellulaire contenant l\u2019\u03b1-synucl\u00e9ine issue des neurones sur-exprimant l\u2019\u03b1-synucl\u00e9ine signifiant que le contact cellule \u00e0 cellule n\u2019est pas obligatoire. Le mode de transport de l\u2019\u03b1-synucl\u00e9ine d\u2019un neurone \u00e0 l\u2019autre n\u2019est pas connu actuellement. Divers m\u00e9canismes pourraient \u00eatre en cause :\u2022le relargage de l\u2019\u03b1-synucl\u00e9ine libre dans le milieu extracellulaire ;\u2022l\u2019acc\u00e8s direct aux neurones voisins par voie transmembranaire ;\u2022un ph\u00e9nom\u00e8ne d\u2019exocytose\u2013endocytose ;\u2022un m\u00e9canisme de lib\u00e9ration et captation via les exosomes ;\u2022un transfert via des nanotubes membranaires intercellulaires ;\u2022une transmission par contact synaptique direct.\n",
            "cite_spans": [
                {
                    "start": 341,
                    "end": 345,
                    "mention": "[53]",
                    "ref_id": "BIBREF53"
                }
            ],
            "section": "Exp\u00e9rimentations in vitro en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Au-del\u00e0 de la transmission de neurones \u00e0 neurones, une transmission de l\u2019\u03b1-synucl\u00e9ine des neurones vers les astrocytes selon des m\u00e9canismes d\u2019exo- et d\u2019endocytose est \u00e9galement possible [54]. Les astrocytes accumulant de l\u2019\u03b1-synucl\u00e9ine vont lib\u00e9rer cytokines et chemokines contribuant ainsi au d\u00e9clenchement d\u2019une r\u00e9action inflammatoire.",
            "cite_spans": [
                {
                    "start": 186,
                    "end": 190,
                    "mention": "[54]",
                    "ref_id": "BIBREF54"
                }
            ],
            "section": "Exp\u00e9rimentations in vitro en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Apr\u00e8s la constatation que de l\u2019\u03b1-synucl\u00e9ine et des CL pouvaient appara\u00eetre dans des cellules neurales greff\u00e9es \u00e0 des patients parkinsoniens, plusieurs \u00e9quipes ont mis en \u00e9vidence exp\u00e9rimentalement la transmission directe, in situ, d\u2019agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine \u00e0 de telles cellules neurales greff\u00e9es. Desplats et al. ont rapport\u00e9, en 2009, que la greffe de cellules souches dans l\u2019hippocampe de souris transg\u00e9niques sur-exprimant l\u2019\u03b1-synucl\u00e9ine humaine entra\u00eenait l\u2019accumulation d\u2019\u03b1-synucl\u00e9ine dans les cellules greff\u00e9es sans toutefois formation de fibrilles ou de CL [53]. Hansen et al. ont montr\u00e9, en 2011, que la greffe de neurones embryonnaires m\u00e9senc\u00e9phaliques murins dans le striatum de souris transg\u00e9niques sur-exprimant l\u2019\u03b1-synucl\u00e9ine humaine d\u00e9clenchait 6 mois apr\u00e8s la greffe, l\u2019accumulation dans les cellules greff\u00e9es d\u2019\u03b1-synucl\u00e9ine monom\u00e9rique mais aussi oligom\u00e9rique et m\u00eame fibrillaire [55]. D\u2019autre part, chez des rats dont les neurones de la substantia nigra expriment l\u2019\u03b1-synucl\u00e9ine humaine, il a \u00e9t\u00e9 mis en \u00e9vidence l\u2019accumulation d\u2019\u03b1-synucl\u00e9ine humaine dans les terminaisons striatales. Lorsque, dans ce m\u00eame mod\u00e8le, une greffe de cellules embryonnaires de rat est r\u00e9alis\u00e9e dans le striatum, le greffon durant les premi\u00e8res semaines ne va pas accumuler d\u2019\u03b1-synucl\u00e9ine puis les semaines suivantes, une accumulation d\u2019abord d\u2019\u03b1-synucl\u00e9ine humaine puis d\u2019\u03b1-synucl\u00e9ine de rat va \u00eatre observ\u00e9e, sugg\u00e9rant un transfert de cellule \u00e0 cellule de l\u2019\u03b1-synucl\u00e9ine le long de la voie nigro-striatale et un processus d\u2019amor\u00e7age au sein du greffon [56].",
            "cite_spans": [
                {
                    "start": 564,
                    "end": 568,
                    "mention": "[53]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 896,
                    "end": 900,
                    "mention": "[55]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1548,
                    "end": 1552,
                    "mention": "[56]",
                    "ref_id": "BIBREF56"
                }
            ],
            "section": "Transfert de l\u2019\u03b1-synucl\u00e9ine agr\u00e9g\u00e9e \u00e0 des cellules neurales greff\u00e9es ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "L\u2019inoculation intrac\u00e9r\u00e9brale d\u2019homog\u00e9nats de cerveau de souris transg\u00e9niques (TgM83) \u00e2g\u00e9es et cliniquement malades exprimant l\u2019\u03b1-synucl\u00e9ine humaine mut\u00e9e A53T insoluble et phosphoryl\u00e9e d\u00e9clenche chez de jeunes souris TgM83 une maladie motrice typique et pr\u00e9coce [57], [58]. Cette maladie s\u2019accompagne de l\u2019accumulation intrac\u00e9r\u00e9brale d\u2019\u03b1-synucl\u00e9ine insoluble et phosphoryl\u00e9e en S\u00e9rine 129 d\u00e9tect\u00e9e en Western Blot et par immunocytochimie. Les souris t\u00e9moins c\u2019est-\u00e0-dire TgM83 non inocul\u00e9es ou inocul\u00e9es \u00e0 partir d\u2019homog\u00e9nats de cerveaux de souris TgM83 jeunes et non malades ont une dur\u00e9e de survie identique et significativement plus longue que les souris inocul\u00e9es \u00e0 partir d\u2019homog\u00e9nats de cerveau de souris \u00e2g\u00e9es et malades [57]. Dans le cerveau des souris inocul\u00e9es avec une solution sans homog\u00e9nats de cerveau, il n\u2019y a pas d\u2019accumulation d\u2019\u03b1-synucl\u00e9ine [58]. De plus, les souris KO n\u2019exprimant pas le g\u00e8ne de l\u2019\u03b1-synucl\u00e9ine ne d\u00e9veloppent pas la maladie et ont une longue survie indiquant l\u2019importance de l\u2019\u03b1-synucl\u00e9ine de l\u2019h\u00f4te pour la transmission de la maladie. L\u2019\u03b1-synucl\u00e9ine anormale se propage \u00e0 partir des sites d\u2019injection (striatum ou cortex) \u00e0 l\u2019ensemble du SNC avec une atteinte pr\u00e9f\u00e9rentielle des r\u00e9gions c\u00e9r\u00e9brales les plus connect\u00e9es avec les r\u00e9gions inocul\u00e9es [58]. Des r\u00e9sultats identiques sont obtenus \u00e0 partir non plus d\u2019homog\u00e9nats de cerveaux mais de fibrilles synth\u00e9tiques d\u2019\u03b1-synucl\u00e9ine humaine [59].",
            "cite_spans": [
                {
                    "start": 262,
                    "end": 266,
                    "mention": "[57]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 268,
                    "end": 272,
                    "mention": "[58]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 728,
                    "end": 732,
                    "mention": "[57]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 860,
                    "end": 864,
                    "mention": "[58]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1283,
                    "end": 1287,
                    "mention": "[58]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1424,
                    "end": 1428,
                    "mention": "[59]",
                    "ref_id": "BIBREF59"
                }
            ],
            "section": "Transmission et propagation de l\u2019\u03b1-synucl\u00e9ine de cellule \u00e0 cellule et recrutement de l\u2019\u03b1-synucl\u00e9ine endog\u00e8ne chez des souris transg\u00e9niques ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Le d\u00e9clenchement possible d\u2019une maladie li\u00e9e \u00e0 l\u2019atteinte de la voie nigro-striatale, chez des souris sauvages non transg\u00e9niques, apr\u00e8s inoculation d\u2019\u03b1-synucl\u00e9ine constitue un argument important en faveur du r\u00f4le de l\u2019\u03b1-synucl\u00e9ine dans la d\u00e9g\u00e9n\u00e9rescence de cette voie nigro-striatale [59]. C\u2019est ainsi que, 30 jours apr\u00e8s injection unilat\u00e9rale intra-striatale d\u2019\u03b1-synucl\u00e9ine synth\u00e9tique sous forme fibrillaire dans le striatum dorsal de souris sauvages, des d\u00e9p\u00f4ts d\u2019\u03b1-synucl\u00e9ine hyperphosphoryl\u00e9e sont visibles au site d\u2019injection, des LN et des CL sont pr\u00e9sents dans des zones ipsilat\u00e9rales connect\u00e9es au striatum comme les couches IV\u2013V du cortex ou le bulbe olfactif confirmant la conversion de l\u2019\u03b1-synucl\u00e9ine endog\u00e8ne de ces souris sauvages. L\u2019accumulation des CL est aussi observ\u00e9e de mani\u00e8re bilat\u00e9rale dans les zones de projection bilat\u00e9rales du striatum comme les amygdales sugg\u00e9rant une transmission de cellule \u00e0 cellule le long des voies de connections inter-neuronales. L\u2019accumulation d\u2019\u03b1-synucl\u00e9ine augmente de j90 \u00e0 j180 et va int\u00e9resser de nombreuses r\u00e9gions du SNC. L\u2019accumulation d\u2019\u03b1-synucl\u00e9ine dans la substantia nigra pars compacta s\u2019accompagne d\u2019une diminution unilat\u00e9rale des neurones dopaminergiques et d\u2019une atteinte clinique de la coordination et de l\u2019\u00e9quilibre des animaux.",
            "cite_spans": [
                {
                    "start": 284,
                    "end": 288,
                    "mention": "[59]",
                    "ref_id": "BIBREF59"
                }
            ],
            "section": "Accumulation d\u2019\u03b1-synucl\u00e9ine et d\u00e9g\u00e9n\u00e9rescence de la voie dopaminergique nigro-striatale chez des souris non transg\u00e9niques ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "L\u2019\u00e9quipe de Prusiner et al. a mis en \u00e9vidence que l\u2019inoculation intrac\u00e9r\u00e9brale d\u2019homog\u00e9nats de cerveau issus de deux patients d\u00e9c\u00e9d\u00e9s d\u2019atrophie multisyst\u00e9matis\u00e9e (MSA) d\u00e9clenchait une maladie neurologique chez des souris transg\u00e9niques h\u00e9t\u00e9rozygotes pour la mutation A53T du g\u00e8ne de l\u2019\u03b1-synucl\u00e9ine [60]. Contrairement aux souris homozygotes pour cette mutation, les souris h\u00e9t\u00e9rozygotes ne d\u00e9clarent pas de maladie naturelle au cours du vieillissement. Dans le cerveau de ces souris inocul\u00e9es, il est mis en \u00e9vidence une gliose astrocytaire avec une activation microgliale et des d\u00e9p\u00f4ts diffus d\u2019\u03b1-synucl\u00e9ine phosphoryl\u00e9e sensible \u00e0 la prot\u00e9inase K et insoluble dans les d\u00e9tergents. Les d\u00e9p\u00f4ts, abondants surtout dans les r\u00e9gions sous-corticales, sont situ\u00e9s dans les neurones ou leurs prolongements. Ces donn\u00e9es sont en faveur d\u2019une possible transmissibilit\u00e9 de la MSA.",
            "cite_spans": [
                {
                    "start": 298,
                    "end": 302,
                    "mention": "[60]",
                    "ref_id": "BIBREF60"
                }
            ],
            "section": "Exp\u00e9riences de transmission des synucl\u00e9inopathies humaines chez l\u2019animal ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "L\u2019injection de pr\u00e9parations enrichies en \u03b1-synucl\u00e9ine insoluble issues du cerveau de patients atteints de d\u00e9mence \u00e0 corps de Lewy \u00e0 des souris sauvage est \u00e9galement capable d\u2019induire une pathologie de type Lewy, mais avec une efficacit\u00e9 moindre que celle observ\u00e9e avec des fibrilles synth\u00e9tiques [61].",
            "cite_spans": [
                {
                    "start": 296,
                    "end": 300,
                    "mention": "[61]",
                    "ref_id": "BIBREF61"
                }
            ],
            "section": "Exp\u00e9riences de transmission des synucl\u00e9inopathies humaines chez l\u2019animal ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Plus r\u00e9cemment, il a \u00e9t\u00e9 montr\u00e9 que l\u2019inoculation de fractions enrichies en CL provenant de la substantia nigra de patients d\u00e9c\u00e9d\u00e9s de maladie de Parkinson idiopathique \u00e0 des souris sauvages C57BL/6 entra\u00eene, \u00e0 4 mois de l\u2019inoculation, une d\u00e9g\u00e9n\u00e9rescence de la voie nigro-stri\u00e9e et une accumulation d\u2019\u03b1-synucl\u00e9ine r\u00e9sistante \u00e0 la prot\u00e9inase K et phosphoryl\u00e9e dans la substantia nigra, le striatum et le cortex [62]. Les souris pr\u00e9sentent des anomalies motrices mises en \u00e9vidence par le test du rotarod. La d\u00e9g\u00e9n\u00e9rescence de la voie nigro-stri\u00e9e n\u2019est pas observ\u00e9e en cas d\u2019inoculation de ces pr\u00e9parations \u00e0 des souris KO pour le g\u00e8ne de l\u2019\u03b1-synucl\u00e9ine indiquant que l\u2019accumulation se fait \u00e0 partir de l\u2019\u03b1-synucl\u00e9ine endog\u00e8ne. L\u2019inoculation de fractions c\u00e9r\u00e9brales provenant des m\u00eames patients mais d\u00e9pourvues de CL n\u2019occasionne pas d\u2019accumulation d\u2019\u03b1-synucl\u00e9ine. L\u2019inoculation de CL provenant de la substantia nigra des m\u00eames patients parkinsoniens dans la substantia nigra de macaques entra\u00eene \u00e0 partir de 3 mois une diminution de l\u2019innervation striatale mise en \u00e9vidence sur le DaTSCAN. Lorsque les animaux sont sacrifi\u00e9s pr\u00e9cocement, 14 mois apr\u00e8s l\u2019inoculation, il est mis en \u00e9vidence une accumulation d\u2019\u03b1-synucl\u00e9ine dans plusieurs r\u00e9gions c\u00e9r\u00e9brales connect\u00e9es \u00e0 la substantia nigra et une d\u00e9g\u00e9n\u00e9rescence mod\u00e9r\u00e9e de la voie nigro-stri\u00e9e compatible avec l\u2019absence de signes cliniques [62].",
            "cite_spans": [
                {
                    "start": 410,
                    "end": 414,
                    "mention": "[62]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 1388,
                    "end": 1392,
                    "mention": "[62]",
                    "ref_id": "BIBREF62"
                }
            ],
            "section": "Exp\u00e9riences de transmission des synucl\u00e9inopathies humaines chez l\u2019animal ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "L\u2019existence de diff\u00e9rentes souches de ce que l\u2019on pourrait appeler par facilit\u00e9 de langage des prions d\u2019\u03b1-synucl\u00e9ine a \u00e9t\u00e9 propos\u00e9e par les prionologues d\u00e8s l\u2019\u00e9mergence de l\u2019hypoth\u00e8se prion dans les synucl\u00e9inopathies. La diversit\u00e9 des souches pourrait, au moins en partie, expliquer la diversit\u00e9 des formes de synucl\u00e9inopathies (maladie de Parkinson, d\u00e9mence \u00e0 corps de Lewy, atrophie multisyst\u00e9matis\u00e9e) et la diversit\u00e9 ph\u00e9notypique au sein de chacune de ces formes. Au-del\u00e0 des aspects fondamentaux, cette question pourrait avoir des cons\u00e9quences op\u00e9rationnelles si l\u2019on se souvient que l\u2019efficacit\u00e9 des proc\u00e9dures de d\u00e9contamination et des compos\u00e9s anti-prion d\u00e9velopp\u00e9s \u00e0 des fins th\u00e9rapeutiques varient selon les souches. L\u2019\u00e9quipe de Lee et al. a montr\u00e9 que des fibres d\u2019\u03b1-synucl\u00e9ine recombinante ayant des propri\u00e9t\u00e9s biochimiques diff\u00e9rentes n\u2019avaient pas la m\u00eame capacit\u00e9 d\u2019induire une tauopathie in vitro et in vivo, sugg\u00e9rant un lien entre structure des assemblages d\u2019\u03b1-synucl\u00e9ine et pouvoir pathog\u00e8ne \u00e9vocateur d\u2019un effet souche [63]. Cette hypoth\u00e8se a \u00e9t\u00e9 r\u00e9cemment confirm\u00e9e par un travail franco-belge montrant que l\u2019injection intrac\u00e9r\u00e9brale d\u2019assemblages d\u2019\u03b1-synucl\u00e9ine de structures diff\u00e9rentes induisait des ph\u00e9notypes distincts chez le rat [64]. \u00c0 ce jour, les diff\u00e9rentes souches pr\u00e9sentes chez l\u2019homme n\u2019ont pas \u00e9t\u00e9 clairement isol\u00e9es et les assemblages d\u2019\u03b1-synucl\u00e9ine responsables de la maladie de Parkinson, de la d\u00e9mence \u00e0 corps de Lewy et des diff\u00e9rentes MSA ne sont pas connus.",
            "cite_spans": [
                {
                    "start": 1038,
                    "end": 1042,
                    "mention": "[63]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1256,
                    "end": 1260,
                    "mention": "[64]",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "Existe-t-il un ph\u00e9nom\u00e8ne de souches\u00a0? ::: Exp\u00e9rimentations in vivo en faveur des ph\u00e9nom\u00e8nes de \u00ab\u00a0seeding and spreading\u00a0\u00bb ::: Arguments en faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "En faisant le constat que certaines structures c\u00e9r\u00e9brales sont toujours touch\u00e9es par la pathologie de Lewy quand d\u2019autres sont int\u00e8gres, Braak et al. ont propos\u00e9 un sc\u00e9nario de progression temporo-spatiale de la pathologie de Lewy [38]. Grossi\u00e8rement ascendante, elle est class\u00e9e en 6 stades (Tableau 1\n) : les premi\u00e8res l\u00e9sions enc\u00e9phaliques sont observ\u00e9es dans le noyau dorsal du vague, le bulbe olfactif et les noyaux olfactifs ant\u00e9rieurs au stade 1. Des agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine sont alors d\u00e9j\u00e0 pr\u00e9sents dans les centres sympathiques m\u00e9dullaires, dans les axones des eff\u00e9rences vagales (noyau dorsal du vague) et au niveau du SNE. Au stade 2, les l\u00e9sions gagnent les noyaux du raph\u00e9 et le locus c\u0153ruleus. C\u2019est \u00e0 partir du stade 3 que le m\u00e9senc\u00e9phale et la substance noire sont touch\u00e9s conjointement \u00e0 certains noyaux de la base (noyau basal de Meynert) et \u00e0 l\u2019amygdale. L\u2019atteinte de l\u2019amygdale est massive au stade 4, et s\u2019accompagne de l\u00e9sions du m\u00e9socortex temporal et de la corne d\u2019Amon. Puis l\u2019atteinte corticale gagne l\u2019insula et le cortex cingulaire (stade 5) et le n\u00e9ocortex dans son ensemble (stade 6).",
            "cite_spans": [
                {
                    "start": 231,
                    "end": 235,
                    "mention": "[38]",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Est-il possible d\u2019int\u00e9grer l\u2019hypoth\u00e8se prion-like\u00a0avec la progression neuropathologique de la maladie de Parkinson\u00a0?",
            "ref_spans": [
                {
                    "start": 293,
                    "end": 302,
                    "mention": "Tableau 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Ce mod\u00e8le de progression s\u00e9quentielle est confort\u00e9 par des arguments cliniques et anatomiques. Des \u00e9tudes \u00e9pid\u00e9miologiques prospectives ont montr\u00e9 que l\u2019anosmie, la constipation et les troubles du comportement en sommeil paradoxal constituent des signes pr\u00e9curseurs de la maladie de Parkinson (revue dans [65]). L\u2019atteinte des centres autonomes et olfactifs au stade 1 et du locus subc\u0153ruleus au stade 2 rendrait compte, respectivement, de ces signes cliniques (Tableau 1). Prenant exemple sur la transmission du prion, Braak et al. posent l\u2019hypoth\u00e8se d\u2019un pathog\u00e8ne neurotoxique qui provoquerait une atteinte initiale des structures nerveuses ent\u00e9riques en d\u00e9clenchant in situ une agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine. Le processus pathologique serait v\u00e9hicul\u00e9 par transport axonal r\u00e9trograde et par voie trans-synaptique. Il gagnerait le SNC et plus pr\u00e9cis\u00e9ment le noyau dorsal moteur du vague en suivant l\u2019innervation vagale comme cela a \u00e9t\u00e9 d\u00e9crit pour l\u2019agent bovin qui se propage via le syst\u00e8me nerveux autonome associ\u00e9 au tube digestif dans la variante de la maladie de Creutzfeldt-Jakob [29] ou pour des traceurs neuronaux [66]. Dans ce mod\u00e8le, la substance noire n\u2019est en d\u00e9finitive que l\u2019un des maillons de cette cha\u00eene d\u2019\u00e9v\u00e8nements propagatifs.",
            "cite_spans": [
                {
                    "start": 305,
                    "end": 309,
                    "mention": "[65]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1087,
                    "end": 1091,
                    "mention": "[29]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 1123,
                    "end": 1127,
                    "mention": "[66]",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Est-il possible d\u2019int\u00e9grer l\u2019hypoth\u00e8se prion-like\u00a0avec la progression neuropathologique de la maladie de Parkinson\u00a0?",
            "ref_spans": [
                {
                    "start": 462,
                    "end": 471,
                    "mention": "Tableau 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Les propri\u00e9t\u00e9s biologiques de l\u2019\u03b1-synucl\u00e9ine (capacit\u00e9 \u00e0 s\u2019agr\u00e9ger, s\u00e9cr\u00e9tion, recapture) viennent logiquement s\u2019int\u00e9grer dans l\u2019hypoth\u00e8se de Braak. Il est tentant d\u2019imaginer qu\u2019une fois la formation d\u2019agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine initi\u00e9e dans le SNE ou les voies olfactives, l\u2019\u03b1-synucl\u00e9ine pathologique se propage de proche en proche le long de voies anatomiques bien d\u00e9finies reproduisant la progression temporo-spatiale propos\u00e9e par Braak et al. (Fig. 3\n). Plusieurs donn\u00e9es exp\u00e9rimentales viennent renforcer cette hypoth\u00e8se. Dans une \u00e9tude anatomique tr\u00e8s pr\u00e9cise r\u00e9alis\u00e9e chez le rat, Phillips et al. ont montr\u00e9 que les eff\u00e9rences vagales, qui trouvent leur origine dans le noyau dorsal du vague, expriment fortement l\u2019\u03b1-synucl\u00e9ine et qu\u2019elles ne font synapse qu\u2019avec des neurones ent\u00e9riques eux aussi riches en \u03b1-synucl\u00e9ine. Ces donn\u00e9es sugg\u00e8rent l\u2019existence d\u2019une voie anatomique contenant beaucoup d\u2019\u03b1-synucl\u00e9ine entre l\u2019intestin et le cerveau qui pourrait propager le processus pathologique du SNC au SNE et vice versa [67]. Ainsi des exp\u00e9riences d\u2019injection locale d\u2019\u03b1-synucl\u00e9ine dans diff\u00e9rentes r\u00e9gion du SNC et du SNE ont permis de montrer que l\u2019\u03b1-synucl\u00e9ine pathologique pouvait diffuser in vivo dans des r\u00e9gions connect\u00e9es anatomiquement :\u2022l\u2019injection st\u00e9r\u00e9otaxique de formes fibrillaires d\u2019\u03b1-synucl\u00e9ine humaine dans le striatum dorsal de souris provoque, comme on l\u2019a vu plus haut, non seulement la formation de corps et de prolongements de Lewy au site d\u2019injection mais aussi, apr\u00e8s 3 \u00e0 6 mois, dans l\u2019amygdale, la substance noire pars compacta, le bulbe olfactif et les couches IV et V du n\u00e9ocortex ipsilat\u00e9raux [59] ;\u2022l\u2019\u03b1-synucl\u00e9ine surexprim\u00e9e dans le noyau dorsal moteur du vague \u00e0 l\u2019aide d\u2019un vecteur viral gagne progressivement le complexe locus c\u0153ruleus/subc\u0153ruleus, l\u2019hypothalamus et l\u2019amygdale homolat\u00e9raux et \u00e0 un moindre degr\u00e9 contralat\u00e9raux [68] ;\u2022des formes fibrillaires d\u2019\u03b1-synucl\u00e9ine inject\u00e9es dans la paroi de l\u2019estomac et du duod\u00e9num sont transport\u00e9es par le nerf vague jusqu\u2019au noyau dorsal moteur du vague [69] ;\u2022une injection dans le bulbe olfactif de formes oligom\u00e9riques et fibrillaires entra\u00eene \u00e0 terme la pr\u00e9sence d\u2019inclusions d\u2019\u03b1-synucleine dans le cortex frontal [70].\n",
            "cite_spans": [
                {
                    "start": 1023,
                    "end": 1027,
                    "mention": "[67]",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 1625,
                    "end": 1629,
                    "mention": "[59]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 1865,
                    "end": 1869,
                    "mention": "[68]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 2037,
                    "end": 2041,
                    "mention": "[69]",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 2201,
                    "end": 2205,
                    "mention": "[70]",
                    "ref_id": "BIBREF70"
                }
            ],
            "section": "Est-il possible d\u2019int\u00e9grer l\u2019hypoth\u00e8se prion-like\u00a0avec la progression neuropathologique de la maladie de Parkinson\u00a0?",
            "ref_spans": [
                {
                    "start": 445,
                    "end": 451,
                    "mention": "Fig. 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "Si l\u2019on admet que la progression de la maladie de Parkinson se fait selon le mod\u00e8le de Braak par un m\u00e9canisme \u00ab prion-like \u00bb allant de la p\u00e9riph\u00e9rie vers le SNC, il reste \u00e0 d\u00e9terminer quel pourrait \u00eatre le facteur d\u00e9clenchant (Fig. 3).",
            "cite_spans": [],
            "section": "Quel pourrait-\u00eatre le facteur d\u00e9clenchant\u00a0?",
            "ref_spans": [
                {
                    "start": 227,
                    "end": 233,
                    "mention": "Fig. 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "Pour Braak, il pourrait s\u2019agir d\u2019un agent pathog\u00e8ne neurotrope, possiblement un virus qui progresserait de la muqueuse olfactive vers le lobe temporal ou qui contaminerait la salive puis l\u2019estomac \u00e0 partir des s\u00e9cr\u00e9tions nasales et \u00e0 partir du tube digestif gagnerait le tronc c\u00e9r\u00e9bral via le SNE. Parmi les virus qui pourraient \u00eatre en cause, notons que l\u2019influenza A est un virus \u00e0 l\u2019origine de ph\u00e9nom\u00e8nes auto-immuns qui a un tropisme particulier pour la substantia nigra, le cervelet ou l\u2019hippocampe. L\u2019implication d\u2019autres virus comme l\u2019herp\u00e8s simplex ou le coronavirus a \u00e9t\u00e9 \u00e9galement \u00e9voqu\u00e9e [71].",
            "cite_spans": [
                {
                    "start": 599,
                    "end": 603,
                    "mention": "[71]",
                    "ref_id": "BIBREF71"
                }
            ],
            "section": "Quel pourrait-\u00eatre le facteur d\u00e9clenchant\u00a0?",
            "ref_spans": []
        },
        {
            "text": "Des arguments exp\u00e9rimentaux plaident, depuis longtemps, pour une origine inflammatoire de la maladie de Parkinson avec l\u2019observation dans les cerveaux de patients parkinsoniens d\u2019une augmentation du nombre de cellules microgliales activ\u00e9es et de l\u2019expression de cytokines pro-inflammatoires [72], [73]. Des arguments \u00e9pid\u00e9miologiques plaident aussi en faveur de cette possible origine inflammatoire. Ainsi, une \u00e9tude r\u00e9trospective portant sur 196 patients parkinsoniens appari\u00e9s sur le sexe et l\u2019\u00e2ge \u00e0 196 t\u00e9moins de population g\u00e9n\u00e9rale a montr\u00e9 que les parkinsoniens avaient deux fois plus d\u2019ant\u00e9c\u00e9dents d\u2019allergie de type asthme, rhinites allergiques ou saisonni\u00e8res que les t\u00e9moins [74]. Cependant, le caract\u00e8re r\u00e9trospectif et l\u2019effectif limit\u00e9 incitent \u00e0 consid\u00e9rer les r\u00e9sultats de cette \u00e9tude avec prudence. Plus r\u00e9cemment, il a \u00e9t\u00e9 montr\u00e9 que la consommation d\u2019anti-inflammatoires non st\u00e9ro\u00efdiens pourrait diminuer le risque de d\u00e9velopper la maladie de Parkinson [75].",
            "cite_spans": [
                {
                    "start": 291,
                    "end": 295,
                    "mention": "[72]",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 297,
                    "end": 301,
                    "mention": "[73]",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 685,
                    "end": 689,
                    "mention": "[74]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 971,
                    "end": 975,
                    "mention": "[75]",
                    "ref_id": "BIBREF75"
                }
            ],
            "section": "Quel pourrait-\u00eatre le facteur d\u00e9clenchant\u00a0?",
            "ref_spans": []
        },
        {
            "text": "L\u2019implication d\u2019une substance neurotoxique comme cause de la maladie de Parkinson a connu un regain d\u2019int\u00e9r\u00eat \u00e0 la fin des ann\u00e9es 1970 et au d\u00e9but des ann\u00e9es 1980 par l\u2019observation de cas de syndromes parkinsoniens aigus apr\u00e8s injection de MPTP. En 1976, un jeune toxicomane am\u00e9ricain a d\u00e9velopp\u00e9 un syndrome parkinsonien quelques jours apr\u00e8s s\u2019\u00eatre inject\u00e9 un opio\u00efde de synth\u00e8se contenant des traces de MPTP. Son d\u00e9c\u00e8s d\u2019une overdose deux ans plus tard a permis de mettre en \u00e9vidence, \u00e0 l\u2019autopsie, une destruction des neurones pigment\u00e9s dopaminergiques de la substantia nigra avec m\u00eame des inclusions pouvant ressembler \u00e0 des corps de Lewy [76]. L\u2019observation de quatre autres cas quelques ann\u00e9es apr\u00e8s a permis de confirmer le lien de cause \u00e0 effet entre l\u2019injection du MPTP et l\u2019\u00e9mergence de ce syndrome parkinsonien s\u00e9v\u00e8re r\u00e9pondant au traitement dopaminergique [77]. Le MPTP a \u00e9t\u00e9 ensuite utilis\u00e9, comme la 6-OHDA, pour g\u00e9n\u00e9rer des mod\u00e8les de syndromes parkinsoniens chez l\u2019animal de laboratoire. Cependant, ces neurotoxiques sont \u00e0 l\u2019origine de syndromes parkinsoniens aigus ne reproduisant pas l\u2019apparition lente et progressive des sympt\u00f4mes chez l\u2019homme. De nombreuses \u00e9tudes \u00e9pid\u00e9miologiques ont montr\u00e9 que l\u2019exposition professionnelle et m\u00eame non professionnelle \u00e0 des pesticides augmentait le risque de d\u00e9velopper une maladie de Parkinson [78]. Cette association, mise en \u00e9vidence avec un grand nombre de pesticides, pr\u00e9sente dans certains cas une relation effet-dose [79]. Le stress oxydatif et le dysfonctionnement mitochondrial sont deux m\u00e9canismes physiopathologiques impliqu\u00e9s dans les mod\u00e8les exp\u00e9rimentaux et dans les formes g\u00e9n\u00e9tiques de maladie de Parkinson. Une \u00e9tude cas-t\u00e9moin a rapport\u00e9 une association entre l\u2019utilisation de pesticides \u00e0 l\u2019origine d\u2019un stress oxydatif comme le paraquat ou inhibant le complexe I mitochondrial comme la rot\u00e9none [80]. Avec ce dernier pesticide, un mod\u00e8le animal reproduisant la progression \u00ab prion-like \u00bb de la maladie de Parkinson selon le mod\u00e8le de Braak a pu \u00eatre mis au point [81]. L\u2019administration par sonde gastrique de 5 mg/kg/jour de rot\u00e9none chez la souris sauvage C57BL/6 permet d\u2019observer, apr\u00e8s 1 mois et demi de traitement, des agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine, d\u2019\u03b1-synucl\u00e9ine phosphoryl\u00e9e et une gliose dans le syst\u00e8me nerveux ent\u00e9rique. Apr\u00e8s 3 mois, le nombre de ces agr\u00e9gats va diminuer avec l\u2019apparition d\u2019inclusions de plus grande taille. De mani\u00e8re concomitante, une accumulation d\u2019\u03b1-synucl\u00e9ine est observ\u00e9e dans la colonne inter-mediolat\u00e9rale de la m\u0153lle-\u00e9pini\u00e8re et dans le noyau dorso-m\u00e9dial du vague sans perte cellulaire puis, apr\u00e8s 3 mois de traitement, une accumulation d\u2019\u03b1-synucl\u00e9ine et une perte des neurones dopaminergiques sont mis en \u00e9vidence dans la substantia nigra. La perte neuronale et l\u2019accumulation d\u2019\u03b1-synucl\u00e9ine ne sont pas li\u00e9es \u00e0 un effet syst\u00e9mique, sont s\u00e9quentielles, mises en \u00e9vidence uniquement dans les r\u00e9gions connect\u00e9es, accompagn\u00e9es de stigmates d\u2019inflammation et se traduisant par une atteinte clinique motrice qui appara\u00eet seulement au bout de 3 mois.",
            "cite_spans": [
                {
                    "start": 643,
                    "end": 647,
                    "mention": "[76]",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 868,
                    "end": 872,
                    "mention": "[77]",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 1352,
                    "end": 1356,
                    "mention": "[78]",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 1481,
                    "end": 1485,
                    "mention": "[79]",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 1872,
                    "end": 1876,
                    "mention": "[80]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 2040,
                    "end": 2044,
                    "mention": "[81]",
                    "ref_id": "BIBREF81"
                }
            ],
            "section": "Quel pourrait-\u00eatre le facteur d\u00e9clenchant\u00a0?",
            "ref_spans": []
        },
        {
            "text": "Enfin, un autre facteur d\u00e9clenchant pourrait \u00eatre une contamination par l\u2019agent causal lui-m\u00eame qui serait constitu\u00e9 d\u2019assemblage d\u2019\u03b1-synucl\u00e9ine pr\u00e9sent dans l\u2019environnement. La contamination pourrait \u00eatre interhumaine lors de soins m\u00e9dicaux ou lors de proc\u00e9dures chirurgicales comme cela a \u00e9t\u00e9 observ\u00e9 dans les ESST. Cependant, aucun argument \u00e9pid\u00e9miologique n\u2019existe actuellement en faveur d\u2019une telle hypoth\u00e8se. Une autre possibilit\u00e9 serait une contamination \u00e0 partir d\u2019animaux atteints mais il n\u2019est pas certain qu\u2019il existe parmi les animaux consomm\u00e9s de cas naturels de maladie de Parkinson. De plus, les mesures mises en place depuis le milieu des ann\u00e9es 1990 apr\u00e8s les premiers cas de variante de la MCJ (retrait des mat\u00e9riaux \u00e0 risques sp\u00e9cifi\u00e9s comme le SNC et les intestins chez les ruminants) ont grandement limit\u00e9 l\u2019exposition \u00e0 des pathog\u00e8nes associ\u00e9s aux tissus nerveux y compris le syst\u00e8me nerveux autonome.",
            "cite_spans": [],
            "section": "Quel pourrait-\u00eatre le facteur d\u00e9clenchant\u00a0?",
            "ref_spans": []
        },
        {
            "text": "Le sc\u00e9nario de progression de la maladie de Parkinson d\u00e9crit par Braak et al., clair et st\u00e9r\u00e9otyp\u00e9 avec un d\u00e9but par le tube digestif et une progression trans-synaptique du processus pathologique jusqu\u2019au SNC, est encore d\u00e9battu. Si la qualit\u00e9 et l\u2019exhaustivit\u00e9 des marquages immunohistochimiques ne font que peu de doute, la s\u00e9lection des cas et l\u2019interpr\u00e9tation des donn\u00e9es peuvent \u00eatre discut\u00e9es. Ainsi, dans son \u00e9tude princeps publi\u00e9e en 2003, Braak et al. rapportent que la totalit\u00e9 des 41 patients atteints de maladie de Parkinson dont le cerveau a \u00e9t\u00e9 analys\u00e9 ont des l\u00e9sions dans le noyau dorsal moteur du vague [38]. Ceci combin\u00e9 \u00e0 la pr\u00e9sence de corps de Lewy dans le noyau dorsal moteur du vague chez 69/69 des sujets indemnes de maladie de Parkinson, l\u2019a amen\u00e9 \u00e0 conclure que le noyau dorsal moteur du vague \u00e9tait un passage oblig\u00e9 du processus pathologique. Cependant, les crit\u00e8res de s\u00e9lection de ces 69 sujets parmi une large s\u00e9rie de cerveaux de sujets sans signes moteurs \u00e9vocateurs de syndrome parkinsonien, mais qui pr\u00e9sentaient des corps de Lewy \u00e0 l\u2019analyse microscopique ne sont pas mentionn\u00e9s. Un biais de s\u00e9lection ne peut donc pas \u00eatre formellement \u00e9limin\u00e9. Il en va de m\u00eame pour l\u2019article publi\u00e9 3 ans plus tard par la m\u00eame \u00e9quipe sur l\u2019atteinte pr\u00e9coce du SNE chez les patients parkinsoniens qui reposait sur la description pathologique pr\u00e9cise du SNE et du SNC chez 5 sujets s\u00e9lectionn\u00e9s [82]. Depuis ces publications des s\u00e9ries neuropathologiques ont montr\u00e9 qu\u2019une proportion non n\u00e9gligeables de cas ne suivaient pas la pr\u00e9diction de progression rostro-caudale propos\u00e9e par Braak. Sur 71 cas analys\u00e9s, Kalaitzakis et al. ont montr\u00e9 que 22 sujets avaient une atteinte s\u00e9v\u00e8re de la substantia nigra avec peu ou pas d\u2019atteinte du noyau dorsal moteur vague [83]. Ces donn\u00e9es ont \u00e9t\u00e9 confirm\u00e9es par une \u00e9tude ind\u00e9pendante publi\u00e9e la m\u00eame ann\u00e9e [84].",
            "cite_spans": [
                {
                    "start": 620,
                    "end": 624,
                    "mention": "[38]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1415,
                    "end": 1419,
                    "mention": "[82]",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 1781,
                    "end": 1785,
                    "mention": "[83]",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 1867,
                    "end": 1871,
                    "mention": "[84]",
                    "ref_id": "BIBREF84"
                }
            ],
            "section": "Arguments en d\u00e9faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Les deux publications originales des \u00e9quipes de Brundin et Kordower montrant la pr\u00e9sence de corps de Lewy (CL) et de neurites de Lewy (NL) dans certains neurones embryonnaires transplant\u00e9s ont re\u00e7u un large \u00e9cho. Il est toutefois important de contrebalancer les r\u00e9sultats de ces \u00e9tudes par ceux de l\u2019\u00e9quipe d\u2019Ole Isacson qui est plus circonspecte quant au r\u00f4le \u00e9ventuel d\u2019un passage de neurone \u00e0 neurone de l\u2019\u03b1-synucl\u00e9ine dans la diffusion de la maladie. En analysant les cerveaux de 5 patients parkinsoniens transplant\u00e9s 9 \u00e0 14 ans auparavant, ils n\u2019ont pas mis en \u00e9vidence de signes de neurod\u00e9g\u00e9n\u00e9rescence ni de d\u00e9p\u00f4ts d\u2019\u03b1-synucl\u00e9ine dans les neurones greff\u00e9s [47]. Bien qu\u2019ils n\u2019excluent pas que des corps de Lewy puissent \u00eatre trouv\u00e9s dans les neurones greff\u00e9s, ils incitent \u00e0 la prudence en sugg\u00e9rant qu\u2019il s\u2019agit d\u2019un ph\u00e9nom\u00e8ne rare et qui ne leur semble pas \u00eatre impliqu\u00e9 dans la diffusion du processus pathologique.",
            "cite_spans": [
                {
                    "start": 662,
                    "end": 666,
                    "mention": "[47]",
                    "ref_id": "BIBREF47"
                }
            ],
            "section": "Arguments en d\u00e9faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "Nous l\u2019avons vu, de nombreuses exp\u00e9riences de biologie cellulaire sont venues appuyer l\u2019hypoth\u00e8se d\u2019un passage de neurone \u00e0 neurone de l\u2019\u03b1-synucl\u00e9ine. Il convient l\u00e0 aussi de garder un \u0153il critique car m\u00eame si les exp\u00e9riences propos\u00e9es sont globalement convaincantes, elles ne sont pas exemptes de critiques. Cet aspect a \u00e9t\u00e9 r\u00e9cemment discut\u00e9 dans une excellente revue qui souligne les limites de ces exp\u00e9riences dont certaines ont \u00e9t\u00e9 r\u00e9alis\u00e9es avec des agents de lipofection pour favoriser le passage transmembranaire de l\u2019\u03b1-synucl\u00e9ine ou chez des souris transg\u00e9niques qui sur-expriment massivement l\u2019\u03b1-synucl\u00e9ine humaine et qui sont bien loin de ce qui peut \u00eatre observ\u00e9 en physiopathologie humaine (revue dans [85]).",
            "cite_spans": [
                {
                    "start": 715,
                    "end": 719,
                    "mention": "[85]",
                    "ref_id": "BIBREF85"
                }
            ],
            "section": "Arguments en d\u00e9faveur d\u2019une progression \u00ab\u00a0prion-like\u00a0\u00bb au cours de la maladie de Parkinson",
            "ref_spans": []
        },
        {
            "text": "L\u2019hypoth\u00e8se selon laquelle l\u2019\u03b1-synucl\u00e9ine agr\u00e9g\u00e9e se propagerait selon un mode prion-like permet d\u2019envisager de nouvelles possibilit\u00e9s th\u00e9rapeutiques pour la maladie de Parkinson qui cibleraient directement l\u2019\u03b1-synucl\u00e9ine. Il a \u00e9t\u00e9 ainsi propos\u00e9 qu\u2019une diminution de l\u2019expression et/ou une augmentation de l\u2019\u00e9limination de l\u2019\u03b1-synucl\u00e9ine pourraient permettre de ralentir l\u2019\u00e9volution de la maladie. Une autre strat\u00e9gie \u00ab neuroprotectrice \u00bb consisterait \u00e0 diminuer le niveau de phosphorylation de l\u2019\u03b1-synucl\u00e9ine et par la m\u00eame sa capacit\u00e9 \u00e0 s\u2019agr\u00e9ger. Ces approches ont \u00e9t\u00e9 test\u00e9es dans des mod\u00e8les animaux de la maladie et se sont montr\u00e9es globalement efficaces (revue dans [86]). Il est toutefois important d\u2019attendre les r\u00e9sultats chez l\u2019homme, les \u00e9tudes en cours n\u2019en \u00e9tant pour le moment qu\u2019\u00e0 une phase pr\u00e9coce [86].",
            "cite_spans": [
                {
                    "start": 673,
                    "end": 677,
                    "mention": "[86]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 815,
                    "end": 819,
                    "mention": "[86]",
                    "ref_id": "BIBREF86"
                }
            ],
            "section": "Implications th\u00e9rapeutiques et diagnostiques",
            "ref_spans": []
        },
        {
            "text": "L\u2019approche qui a re\u00e7u le plus d\u2019\u00e9cho est l\u2019utilisation d\u2019anticorps anti-\u03b1-synucl\u00e9ine, comme cela a \u00e9t\u00e9 fait pour le peptide \u03b2-amylo\u00efde dans la maladie d\u2019Alzheimer. En effet, le m\u00e9canisme de propagation implique un passage extracellulaire des assemblages pathologiques qui serait alors plus facilement accessibles. Plusieurs groupes de recherche ont montr\u00e9 que l\u2019immunisation active ou passive contre l\u2019\u03b1-synucl\u00e9ine permettait de diminuer la charge l\u00e9sionnelle et am\u00e9liorait les performances motrices dans des mod\u00e8les de souris transg\u00e9niques de la maladie [87], [88], [89]. Une \u00e9tude pilote par immunisation active contre l\u2019\u03b1-synucl\u00e9ine a \u00e9t\u00e9 propos\u00e9 \u00e0 32 patients parkinsoniens par une Soci\u00e9t\u00e9 de biotechnologie autrichienne (Protocole PD01 AFFITOPE, Clinical Trials NCT01568099). Cette premi\u00e8re \u00e9tape a permis de montrer que cette immunisation \u00e9tait bien support\u00e9e et qu\u2019aucun des patients n\u2019avait d\u00e9velopp\u00e9 d\u2019effets secondaires notables. D\u2019autres protocoles sont en cours avec une \u00e9valuation \u00e0 plus long terme sur l\u2019\u00e9volution de la maladie.",
            "cite_spans": [
                {
                    "start": 555,
                    "end": 559,
                    "mention": "[87]",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 561,
                    "end": 565,
                    "mention": "[88]",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 567,
                    "end": 571,
                    "mention": "[89]",
                    "ref_id": "BIBREF89"
                }
            ],
            "section": "Implications th\u00e9rapeutiques et diagnostiques",
            "ref_spans": []
        },
        {
            "text": "Enfin, les m\u00e9thodes d\u2019amplification du mauvais repliement des prot\u00e9ines, qui ont montr\u00e9 leur int\u00e9r\u00eat dans le diagnostic des maladies \u00e0 prions [90], [91], pourraient \u00eatre adapt\u00e9es \u00e0 l\u2019alpha-synucl\u00e9ine et fournir prochainement \u00e0 la communaut\u00e9 neurologique des outils innovants et tr\u00e8s performants pour le diagnostic et le suivi des alpha-synucleinopathies.",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 146,
                    "mention": "[90]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 148,
                    "end": 152,
                    "mention": "[91]",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Implications th\u00e9rapeutiques et diagnostiques",
            "ref_spans": []
        },
        {
            "text": "L\u2019implication de m\u00e9canismes de type prion dans la survenue et l\u2019aggravation progressive des maladies conformationnelles des prot\u00e9ines du SNC et notamment de la maladie de Parkinson est une avanc\u00e9e conceptuelle importante dans la compr\u00e9hension de la physiopathologie de ces maladies. Cependant, la cause initiale, et il pourrait s\u2019agir d\u2019un ensemble de facteurs (environnementaux, g\u00e9n\u00e9tiques, cellulaires, li\u00e9s au vieillissement\u2026), entra\u00eenant le mauvais repliement et l\u2019agr\u00e9gation de la prot\u00e9ine cible demeure inconnue. Il en est de m\u00eame des m\u00e9canismes de diss\u00e9mination des prot\u00e9ines agr\u00e9g\u00e9es. La corr\u00e9lation entre les signes non moteurs pr\u00e9-symptomatiques et la diffusion s\u00e9quentielle et pr\u00e9dictive de l\u2019\u03b1-synucl\u00e9ine, selon le mod\u00e8le de Braak, font de la maladie de Parkinson un mod\u00e8le tr\u00e8s pertinent, non seulement pour l\u2019\u00e9tude de ces m\u00e9canismes, mais aussi pour tester des traitements sp\u00e9cifiques ciblant les assemblages d\u2019\u03b1-synucl\u00e9ine et leur propagation d\u00e8s la phase pr\u00e9-motrice de la maladie. Il faut enfin insister sur le fait qu\u2019il n\u2019existe actuellement aucun argument permettant de suspecter un risque de transmission interhumaine de la maladie de Parkinson.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Les auteurs d\u00e9clarent ne pas avoir de liens d\u2019int\u00e9r\u00eats.",
            "cite_spans": [],
            "section": "D\u00e9claration de liens d\u2019int\u00e9r\u00eats",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Tableau 1: Corr\u00e9lation anatomo-clinique de la progression temporo-spatiale de la pathologie de Lewy selon le mod\u00e8le de Braak.\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig. 1: Mod\u00e8les de la conversion de la PrPc en PrPsc [61], [62]. A. Mod\u00e8le de polym\u00e9risation assist\u00e9e par une amorce. B. Mod\u00e8le de nucl\u00e9ation-polym\u00e9risation.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig. 2: A. Structure primaire de l\u2019\u03b1-synucl\u00e9ine humaine. L\u2019\u03b1-synucl\u00e9ine humaine est une petite prot\u00e9ine de 140 acides amin\u00e9s divis\u00e9e d\u2019un point de vue fonctionnel en 3 domaines. La partie amino-terminale (r\u00e9sidus 1 \u00e0 60) contient 6 domaines de r\u00e9p\u00e9tition imparfaite (R1 \u00e0 R6) contenant des r\u00e9sidus lysine, impliqu\u00e9s dans la liaison aux lipides et aux membranes cellulaires. Le domaine central (r\u00e9sidus 61 \u00e0 95) joue un r\u00f4le essentiel dans les capacit\u00e9s d\u2019agr\u00e9gation de la prot\u00e9ine alors que l\u2019extr\u00e9mit\u00e9 carboxy-terminale (r\u00e9sidus 96\u2013140) serait responsable de l\u2019activit\u00e9 et contient le principal sites de phosphorylation sur le r\u00e9sidu s\u00e9rine 129. B. Agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine. Des \u00e9tudes in vitro ont montr\u00e9 que l\u2019\u03b1-synucl\u00e9ine est en \u00e9quilibre dynamique. La forme monom\u00e9rique a une capacit\u00e9 naturelle \u00e0 s\u2019agr\u00e9ger en structures amylo\u00efdes gr\u00e2ce \u00e0 son domaine central selon la progression suivante : dim\u00e8res, oligom\u00e8res, protofibrilles et fibrilles puis enfin corps de Lewy.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig. 3: Repr\u00e9sentation sch\u00e9matique des possibles facteurs responsables de l\u2019agr\u00e9gation et de la propagation de l\u2019\u03b1-synucl\u00e9ine selon un m\u00e9canisme prion-like. 1 \u2013 Entr\u00e9e d\u2019un facteur exog\u00e8ne (virus, neurotoxique, agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine) par voie orale ou nasale, \u00e9ventuellement favoris\u00e9e par un ph\u00e9nom\u00e8ne inflammatoire. 2 \u2013 Diss\u00e9mination des agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine ing\u00e9r\u00e9s, inhal\u00e9s ou form\u00e9s, in situ, sous l\u2019influence du virus ou du neurotoxique \u00e0 partir du syst\u00e8me nerveux p\u00e9riph\u00e9rique. L\u2019hypoth\u00e8se alternative serait la propagation directe d\u2019un virus dont la r\u00e9plication p\u00e9riph\u00e9rique ou centrale entra\u00eenerait l\u2019agr\u00e9gation de l\u2019\u03b1-synucl\u00e9ine le long de son trajet. 3 \u2013 Accumulation de l\u2019\u03b1-synucl\u00e9ine dans le tronc c\u00e9r\u00e9bral (voie digestive) ou dans le lobe temporal (voie olfactive). 4 \u2013 Propagation des agr\u00e9gats d\u2019\u03b1-synucl\u00e9ine \u00e0 l\u2019ensemble du cortex.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Atarashi",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Satoh",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Sano",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Fuse",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Yamaguchi",
                    "suffix": ""
                },
                {
                    "first": "al.",
                    "middle": [],
                    "last": "Ishibashi Det",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nat Med",
            "volume": "17",
            "issn": "",
            "pages": "175-178",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Inactivation of the scrapie agent by near monochromatic ultraviolet light",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Latarget",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Muel",
                    "suffix": ""
                },
                {
                    "first": "D.A.",
                    "middle": [],
                    "last": "Haig",
                    "suffix": ""
                },
                {
                    "first": "M.C.",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Alper",
                    "suffix": ""
                }
            ],
            "year": 1970,
            "venue": "Nature",
            "volume": "227",
            "issn": "",
            "pages": "1341-1343",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Special lecture\u00a0\u2013\u00a0The scrapie enigma: insights from radiation experiments (Reprinted from Radiation Research 1993;135:283\u201392)",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Alper",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Int J Radiat Biol",
            "volume": "71",
            "issn": "",
            "pages": "759-768",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Novel proteinaceous infectious particles cause scrapie",
            "authors": [
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Science",
            "volume": "216",
            "issn": "",
            "pages": "136-144",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Haik",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Brandel",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Infect Genet Evol",
            "volume": "26C",
            "issn": "",
            "pages": "303-312",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Physiological and environmental control of yeast prions",
            "authors": [
                {
                    "first": "T.A.",
                    "middle": [],
                    "last": "Chernova",
                    "suffix": ""
                },
                {
                    "first": "K.D.",
                    "middle": [],
                    "last": "Wilkinson",
                    "suffix": ""
                },
                {
                    "first": "Y.O.",
                    "middle": [],
                    "last": "Chernoff",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "FEMS Microbiol Rev",
            "volume": "38",
            "issn": "",
            "pages": "326-344",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation",
            "authors": [
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Si",
                    "suffix": ""
                },
                {
                    "first": "Y.B.",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "White-Grindley",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Majumdar",
                    "suffix": ""
                },
                {
                    "first": "E.R.",
                    "middle": [],
                    "last": "Kandel",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Cell",
            "volume": "140",
            "issn": "",
            "pages": "421-435",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "NMR solution structure of the human prion protein",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Zahn",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Luhrs",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Riek",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "von Schroetter",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Lopez Garcia",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "97",
            "issn": "",
            "pages": "145-150",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Mice devoid of PrP are resistant to scrapie",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "B\u00fceler",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Aguzzi",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Sailer",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Greiner",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Autenried",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Aguet",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Cell",
            "volume": "73",
            "issn": "",
            "pages": "1339-1347",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication",
            "authors": [
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Groth",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Mirenda",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "Cell",
            "volume": "63",
            "issn": "",
            "pages": "673-686",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein",
            "authors": [
                {
                    "first": "G.C.",
                    "middle": [],
                    "last": "Telling",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Mastrianni",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Gabizon",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Torchia",
                    "suffix": ""
                },
                {
                    "first": "F.E.",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Cell",
            "volume": "83",
            "issn": "",
            "pages": "79-90",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Hope",
                    "suffix": ""
                },
                {
                    "first": "L.J.D.",
                    "middle": [],
                    "last": "Morton",
                    "suffix": ""
                },
                {
                    "first": "C.F.",
                    "middle": [],
                    "last": "Farquhar",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Multhaup",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Beyreuther",
                    "suffix": ""
                },
                {
                    "first": "R.H.",
                    "middle": [],
                    "last": "Kimberlin",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "EMBO J",
            "volume": "5",
            "issn": "",
            "pages": "2591-2597",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "X-ray diffraction of scrapie prion rods and PrP peptides",
            "authors": [
                {
                    "first": "J.T.",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Inouye",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Baldwin",
                    "suffix": ""
                },
                {
                    "first": "R.J.",
                    "middle": [],
                    "last": "Fletterick",
                    "suffix": ""
                },
                {
                    "first": "F.E.",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Mol Biol",
            "volume": "252",
            "issn": "",
            "pages": "412-422",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Scrapie prions\u00a0\u2013\u00a0a 3-dimensional model of an infectious fragment (vol. 1, pg 13, 1996)",
            "authors": [
                {
                    "first": "Z.W.",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                },
                {
                    "first": "F.E.",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Folding Design",
            "volume": "1",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Prions",
            "authors": [
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "95",
            "issn": "",
            "pages": "13363-13383",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies",
            "authors": [
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Weissmann",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "FEBS Lett",
            "volume": "389",
            "issn": "",
            "pages": "3-11",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Deadly conformations\u00a0\u2013\u00a0protein misfolding in prion disease",
            "authors": [
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Horwich",
                    "suffix": ""
                },
                {
                    "first": "J.S.",
                    "middle": [],
                    "last": "Weissman",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Cell",
            "volume": "89",
            "issn": "",
            "pages": "499-510",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice",
            "authors": [
                {
                    "first": "W.S.",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "A.W.",
                    "middle": [],
                    "last": "Borkowski",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Faas",
                    "suffix": ""
                },
                {
                    "first": "A.D.",
                    "middle": [],
                    "last": "Steele",
                    "suffix": ""
                },
                {
                    "first": "O.D.",
                    "middle": [],
                    "last": "King",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Neuron",
            "volume": "63",
            "issn": "",
            "pages": "438-450",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases",
            "authors": [
                {
                    "first": "W.S.",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "A.W.",
                    "middle": [],
                    "last": "Borkowski",
                    "suffix": ""
                },
                {
                    "first": "N.E.",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                },
                {
                    "first": "O.D.",
                    "middle": [],
                    "last": "King",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Faas",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Jasanoff",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "110",
            "issn": "",
            "pages": "14759-14764",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "In vitro generation of infectious scrapie prions",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Castilla",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Saa",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Hetz",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Soto",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Cell",
            "volume": "121",
            "issn": "",
            "pages": "195-206",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Cell-free formation of misfolded prion protein with authentic prion infectivity",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Weber",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Giese",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Piening",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Mitteregger",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Thomzig",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Beekes",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "103",
            "issn": "",
            "pages": "15818-15823",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Formation of native prions from minimal components in vitro",
            "authors": [
                {
                    "first": "N.R.",
                    "middle": [],
                    "last": "Deleault",
                    "suffix": ""
                },
                {
                    "first": "B.T.",
                    "middle": [],
                    "last": "Harris",
                    "suffix": ""
                },
                {
                    "first": "J.R.",
                    "middle": [],
                    "last": "Rees",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Supattapone",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "104",
            "issn": "",
            "pages": "9741-9746",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors",
            "authors": [
                {
                    "first": "J.I.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Cali",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Surewicz",
                    "suffix": ""
                },
                {
                    "first": "Q.",
                    "middle": [],
                    "last": "Kong",
                    "suffix": ""
                },
                {
                    "first": "G.J.",
                    "middle": [],
                    "last": "Raymond",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Atarashi",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Biol Chem",
            "volume": "285",
            "issn": "",
            "pages": "14083-14087",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Synthetic mammalian prions",
            "authors": [
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Legname",
                    "suffix": ""
                },
                {
                    "first": "I.V.",
                    "middle": [],
                    "last": "Baskakov",
                    "suffix": ""
                },
                {
                    "first": "H.O.",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Riesner",
                    "suffix": ""
                },
                {
                    "first": "F.E.",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "DeArmond",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Science",
            "volume": "305",
            "issn": "",
            "pages": "673-676",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Strain-specified characteristics of mouse synthetic prions",
            "authors": [
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Legname",
                    "suffix": ""
                },
                {
                    "first": "H.O.",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "I.V.",
                    "middle": [],
                    "last": "Baskakov",
                    "suffix": ""
                },
                {
                    "first": "F.E.",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Dearmond",
                    "suffix": ""
                },
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "102",
            "issn": "",
            "pages": "2168-2173",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "A general model of prion strains and their pathogenicity",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Collinge",
                    "suffix": ""
                },
                {
                    "first": "A.R.",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Science",
            "volume": "318",
            "issn": "",
            "pages": "930-936",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Biochemical and strain properties of CJD prions: complexity versus simplicity",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Haik",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Brandel",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Neurochem",
            "volume": "119",
            "issn": "",
            "pages": "251-261",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain",
            "authors": [
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Brandel",
                    "suffix": ""
                },
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Heath",
                    "suffix": ""
                },
                {
                    "first": "M.W.",
                    "middle": [],
                    "last": "Head",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Levavasseur",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Knight",
                    "suffix": ""
                },
                {
                    "first": "J.L.",
                    "middle": [],
                    "last": "Laplanche",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Ann Neurol",
            "volume": "65",
            "issn": "",
            "pages": "249-256",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Brain targeting through the autonomous nervous system: lessons from prion diseases",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Haik",
                    "suffix": ""
                },
                {
                    "first": "B.A.",
                    "middle": [],
                    "last": "Faucheux",
                    "suffix": ""
                },
                {
                    "first": "J.J.",
                    "middle": [],
                    "last": "Hauw",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Trends Mol Med",
            "volume": "10",
            "issn": "",
            "pages": "107-112",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Haik",
                    "suffix": ""
                },
                {
                    "first": "B.A.",
                    "middle": [],
                    "last": "Faucheux",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Sazdovitch",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Privat",
                    "suffix": ""
                },
                {
                    "first": "J.L.",
                    "middle": [],
                    "last": "Kemeny",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Perret-Liaudet",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat Med",
            "volume": "9",
            "issn": "",
            "pages": "1121-1123",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Llewelyn",
                    "suffix": ""
                },
                {
                    "first": "P.E.",
                    "middle": [],
                    "last": "Hewitt",
                    "suffix": ""
                },
                {
                    "first": "R.S.",
                    "middle": [],
                    "last": "Knight",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Amar",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Cousens",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Mackenzie",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "363",
            "issn": "",
            "pages": "417-421",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies",
            "authors": [
                {
                    "first": "J.W.",
                    "middle": [],
                    "last": "Ironside",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Haemophilia",
            "volume": "12",
            "issn": "Suppl.\u00a01",
            "pages": "8-15",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Maroteaux",
                    "suffix": ""
                },
                {
                    "first": "J.T.",
                    "middle": [],
                    "last": "Campanelli",
                    "suffix": ""
                },
                {
                    "first": "R.H.",
                    "middle": [],
                    "last": "Scheller",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "J Neurosci",
            "volume": "8",
            "issn": "",
            "pages": "2804-2815",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease",
            "authors": [
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Fukushima",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Masliah",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Iwai",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Yoshimoto",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "90",
            "issn": "",
            "pages": "11282-11286",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Mutation in the alpha-synuclein gene identified in families with Parkinson's disease",
            "authors": [
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Polymeropoulos",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Lavedan",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Leroy",
                    "suffix": ""
                },
                {
                    "first": "S.E.",
                    "middle": [],
                    "last": "Ide",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Dehejia",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Dutra",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Science",
            "volume": "276",
            "issn": "",
            "pages": "2045-2047",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Alpha-synuclein in Lewy bodies",
            "authors": [
                {
                    "first": "M.G.",
                    "middle": [],
                    "last": "Spillantini",
                    "suffix": ""
                },
                {
                    "first": "M.L.",
                    "middle": [],
                    "last": "Schmidt",
                    "suffix": ""
                },
                {
                    "first": "V.M.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J.Q.",
                    "middle": [],
                    "last": "Trojanowski",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Jakes",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Goedert",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Nature",
            "volume": "388",
            "issn": "",
            "pages": "839-840",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Alpha-Synuclein is phosphorylated in synucleinopathy lesions",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Fujiwara",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Hasegawa",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Dohmae",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Kawashima",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Masliah",
                    "suffix": ""
                },
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "Goldberg",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Nat Cell Biol",
            "volume": "4",
            "issn": "",
            "pages": "160-164",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Evaluation of alpha-synuclein immunohistochemical methods used by invited experts",
            "authors": [
                {
                    "first": "T.G.",
                    "middle": [],
                    "last": "Beach",
                    "suffix": ""
                },
                {
                    "first": "C.L.",
                    "middle": [],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "R.L.",
                    "middle": [],
                    "last": "Hamilton",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Duda",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Iwatsubo",
                    "suffix": ""
                },
                {
                    "first": "D.W.",
                    "middle": [],
                    "last": "Dickson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Acta Neuropathol",
            "volume": "116",
            "issn": "",
            "pages": "277-288",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Staging of brain pathology related to sporadic Parkinson's disease",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Braak",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Del Tredici",
                    "suffix": ""
                },
                {
                    "first": "U.",
                    "middle": [],
                    "last": "Rub",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "de Vos",
                    "suffix": ""
                },
                {
                    "first": "E.N.",
                    "middle": [],
                    "last": "Jansen Steur",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Braak",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Neurobiol Aging",
            "volume": "24",
            "issn": "",
            "pages": "197-211",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders",
            "authors": [
                {
                    "first": "T.G.",
                    "middle": [],
                    "last": "Beach",
                    "suffix": ""
                },
                {
                    "first": "C.H.",
                    "middle": [],
                    "last": "Adler",
                    "suffix": ""
                },
                {
                    "first": "L.I.",
                    "middle": [],
                    "last": "Sue",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Vedders",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Lue",
                    "suffix": ""
                },
                {
                    "first": "C.L.",
                    "middle": [],
                    "last": "White Iii",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Acta Neuropathol",
            "volume": "119",
            "issn": "",
            "pages": "689-702",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Molecular mechanisms of alpha-synuclein neurodegeneration",
            "authors": [
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Waxman",
                    "suffix": ""
                },
                {
                    "first": "B.I.",
                    "middle": [],
                    "last": "Giasson",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Biochim Biophys Acta",
            "volume": "1792",
            "issn": "",
            "pages": "616-624",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Intravesicular localization and exocytosis of alpha-synuclein and its aggregates",
            "authors": [
                {
                    "first": "H.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Neurosci",
            "volume": "25",
            "issn": "",
            "pages": "6016-6024",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Emmanouilidou",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Melachroinou",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Roumeliotis",
                    "suffix": ""
                },
                {
                    "first": "S.D.",
                    "middle": [],
                    "last": "Garbis",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Ntzouni",
                    "suffix": ""
                },
                {
                    "first": "L.H.",
                    "middle": [],
                    "last": "Margaritis",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Neurosci",
            "volume": "30",
            "issn": "",
            "pages": "6838-6851",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Jang",
                    "suffix": ""
                },
                {
                    "first": "H.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Suk",
                    "suffix": ""
                },
                {
                    "first": "J.W.",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                },
                {
                    "first": "K.P.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Neurochem",
            "volume": "113",
            "issn": "",
            "pages": "1263-1274",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Activity-dependent secretion of alpha-synuclein by enteric neurons",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Paillusson",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Clairembault",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Biraud",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Neunlist",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Derkinderen",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Neurochem",
            "volume": "125",
            "issn": "",
            "pages": "512-517",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation",
            "authors": [
                {
                    "first": "J.Y.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Englund",
                    "suffix": ""
                },
                {
                    "first": "J.L.",
                    "middle": [],
                    "last": "Holton",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Soulet",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Hagell",
                    "suffix": ""
                },
                {
                    "first": "A.J.",
                    "middle": [],
                    "last": "Lees",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Nat Med",
            "volume": "14",
            "issn": "",
            "pages": "501-503",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease",
            "authors": [
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Kordower",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Hauser",
                    "suffix": ""
                },
                {
                    "first": "T.B.",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "C.W.",
                    "middle": [],
                    "last": "Olanow",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Nat Med",
            "volume": "14",
            "issn": "",
            "pages": "504-506",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14\u00a0years",
            "authors": [
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Mendez",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Vinuela",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Astradsson",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Mukhida",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Hallett",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Robertson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Nat Med",
            "volume": "14",
            "issn": "",
            "pages": "507-509",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "Signs of degeneration in 12\u201322-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease",
            "authors": [
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Kurowska",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Englund",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Widner",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Lindvall",
                    "suffix": ""
                },
                {
                    "first": "J.Y.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Brundin",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Parkinsons Dis",
            "volume": "1",
            "issn": "",
            "pages": "83-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Is Parkinson's disease a prion disorder?",
            "authors": [
                {
                    "first": "C.W.",
                    "middle": [],
                    "last": "Olanow",
                    "suffix": ""
                },
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Prusiner",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "106",
            "issn": "",
            "pages": "12571-12572",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation",
            "authors": [
                {
                    "first": "L.C.",
                    "middle": [],
                    "last": "Serpell",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Berriman",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Jakes",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Goedert",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Crowther",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "97",
            "issn": "",
            "pages": "4897-4902",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs",
            "authors": [
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Biere",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Wypych",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Steavenson",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Anafi",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Biol Chem",
            "volume": "275",
            "issn": "",
            "pages": "34574-34579",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Yonetani",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Nonaka",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Masuda",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Inukai",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Oikawa",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Hisanaga",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Biol Chem",
            "volume": "284",
            "issn": "",
            "pages": "7940-7950",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Desplats",
                    "suffix": ""
                },
                {
                    "first": "H.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "E.J.",
                    "middle": [],
                    "last": "Bae",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Patrick",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Rockenstein",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Crews",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "106",
            "issn": "",
            "pages": "13010-13015",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection",
            "authors": [
                {
                    "first": "H.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Oxid Med Cell Longev",
            "volume": "3",
            "issn": "",
            "pages": "283-287",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells",
            "authors": [
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Angot",
                    "suffix": ""
                },
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Bergstrom",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Steiner",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Pieri",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Paul",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Clin Invest",
            "volume": "121",
            "issn": "",
            "pages": "715-725",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Angot",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Steiner",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Lema Tome",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Ekstrom",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Mattsson",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Bjorklund",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS One",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Prion-like acceleration of a synucleinopathy in a transgenic mouse model",
            "authors": [
                {
                    "first": "A.L.",
                    "middle": [],
                    "last": "Mougenot",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Nicot",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Bencsik",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Morignat",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Verchere",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Lakhdar",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Neurobiol Aging",
            "volume": "33",
            "issn": "",
            "pages": "2225-2228",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice",
            "authors": [
                {
                    "first": "K.C.",
                    "middle": [],
                    "last": "Luk",
                    "suffix": ""
                },
                {
                    "first": "V.M.",
                    "middle": [],
                    "last": "Kehm",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "O\u2019Brien",
                    "suffix": ""
                },
                {
                    "first": "J.Q.",
                    "middle": [],
                    "last": "Trojanowski",
                    "suffix": ""
                },
                {
                    "first": "V.M.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Exp Med",
            "volume": "209",
            "issn": "",
            "pages": "975-986",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice",
            "authors": [
                {
                    "first": "K.C.",
                    "middle": [],
                    "last": "Luk",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Kehm",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Carroll",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "O\u2019Brien",
                    "suffix": ""
                },
                {
                    "first": "J.Q.",
                    "middle": [],
                    "last": "Trojanowski",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Science",
            "volume": "338",
            "issn": "",
            "pages": "949-953",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Transmission of multiple system atrophy prions to transgenic mice",
            "authors": [
                {
                    "first": "J.C.",
                    "middle": [],
                    "last": "Watts",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Giles",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Oehler",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Middleton",
                    "suffix": ""
                },
                {
                    "first": "D.T.",
                    "middle": [],
                    "last": "Dexter",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Gentleman",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "110",
            "issn": "",
            "pages": "19555-19560",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "Prion-like spreading of pathological alpha-synuclein in brain",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Masuda-Suzukake",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Nonaka",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Hosokawa",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Oikawa",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Arai",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Akiyama",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Brain",
            "volume": "136",
            "issn": "",
            "pages": "1128-1138",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Recasens",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Dehay",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Bove",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Carballo-Carbajal",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Dovero",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Perez-Villalba",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Ann Neurol",
            "volume": "75",
            "issn": "",
            "pages": "351-362",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "Distinct alpha-synuclein strains differentially promote tau inclusions in neurons",
            "authors": [
                {
                    "first": "J.L.",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Covell",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Daniels",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Iba",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Stieber",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cell",
            "volume": "154",
            "issn": "",
            "pages": "103-117",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Peelaerts",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Bousset",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Van der Perren",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Moskalyuk",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Pulizzi",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Giugliano",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Nature",
            "volume": "522",
            "issn": "",
            "pages": "340-344",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF65": {
            "title": "When does Parkinson disease start?",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Savica",
                    "suffix": ""
                },
                {
                    "first": "W.A.",
                    "middle": [],
                    "last": "Rocca",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Ahlskog",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Arch Neurol",
            "volume": "67",
            "issn": "",
            "pages": "798-801",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF66": {
            "title": "Retrograde tracer technique for assessment of selective and total subdiaphragmatic vagotomies",
            "authors": [
                {
                    "first": "T.L.",
                    "middle": [],
                    "last": "Powley",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Fox",
                    "suffix": ""
                },
                {
                    "first": "H.R.",
                    "middle": [],
                    "last": "Berthoud",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Am J Physiol",
            "volume": "253",
            "issn": "",
            "pages": "R361-R370",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?",
            "authors": [
                {
                    "first": "R.J.",
                    "middle": [],
                    "last": "Phillips",
                    "suffix": ""
                },
                {
                    "first": "G.C.",
                    "middle": [],
                    "last": "Walter",
                    "suffix": ""
                },
                {
                    "first": "S.L.",
                    "middle": [],
                    "last": "Wilder",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Baronowsky",
                    "suffix": ""
                },
                {
                    "first": "T.L.",
                    "middle": [],
                    "last": "Powley",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Neuroscience",
            "volume": "153",
            "issn": "",
            "pages": "733-750",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF68": {
            "title": "Caudo-rostral brain spreading of alpha-synuclein through vagal connections",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Ulusoy",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Rusconi",
                    "suffix": ""
                },
                {
                    "first": "B.I.",
                    "middle": [],
                    "last": "Perez-Revuelta",
                    "suffix": ""
                },
                {
                    "first": "R.E.",
                    "middle": [],
                    "last": "Musgrove",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Helwig",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Winzen-Reichert",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "EMBO Mol Med",
            "volume": "5",
            "issn": "",
            "pages": "1051-1059",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Holmqvist",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Chutna",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Bousset",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Aldrin-Kirk",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Bjorklund",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Acta Neuropathol",
            "volume": "128",
            "issn": "",
            "pages": "805-820",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF70": {
            "title": "Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice",
            "authors": [
                {
                    "first": "N.L.",
                    "middle": [],
                    "last": "Rey",
                    "suffix": ""
                },
                {
                    "first": "G.H.",
                    "middle": [],
                    "last": "Petit",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Bousset",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Melki",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Brundin",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Acta Neuropathol",
            "volume": "126",
            "issn": "",
            "pages": "555-573",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Parkinson's disease: a dual-hit hypothesis",
            "authors": [
                {
                    "first": "C.H.",
                    "middle": [],
                    "last": "Hawkes",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Del Tredici",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Braak",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Neuropathol Appl Neurobiol",
            "volume": "33",
            "issn": "",
            "pages": "599-614",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF72": {
            "title": "Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains",
            "authors": [
                {
                    "first": "P.L.",
                    "middle": [],
                    "last": "McGeer",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Itagaki",
                    "suffix": ""
                },
                {
                    "first": "B.E.",
                    "middle": [],
                    "last": "Boyes",
                    "suffix": ""
                },
                {
                    "first": "E.G.",
                    "middle": [],
                    "last": "McGeer",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Neurology",
            "volume": "38",
            "issn": "",
            "pages": "1285-1291",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF73": {
            "title": "Interleukin-1\u00a0beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Mogi",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Harada",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Kondo",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Riederer",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Inagaki",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Minami",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Neurosci Lett",
            "volume": "180",
            "issn": "",
            "pages": "147-150",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study",
            "authors": [
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Bower",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Maraganore",
                    "suffix": ""
                },
                {
                    "first": "B.J.",
                    "middle": [],
                    "last": "Peterson",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Ahlskog",
                    "suffix": ""
                },
                {
                    "first": "W.A.",
                    "middle": [],
                    "last": "Rocca",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Neurology",
            "volume": "67",
            "issn": "",
            "pages": "494-496",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis",
            "authors": [
                {
                    "first": "J.J.",
                    "middle": [],
                    "last": "Gagne",
                    "suffix": ""
                },
                {
                    "first": "M.C.",
                    "middle": [],
                    "last": "Power",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Neurology",
            "volume": "74",
            "issn": "",
            "pages": "995-1002",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Chronic Parkinsonism secondary to intravenous injection of meperidine analogues",
            "authors": [
                {
                    "first": "G.C.",
                    "middle": [],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "S.P.",
                    "middle": [],
                    "last": "Markey",
                    "suffix": ""
                },
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Ebert",
                    "suffix": ""
                },
                {
                    "first": "E.D.",
                    "middle": [],
                    "last": "Caine",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Reichert",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "Psychiatry Res",
            "volume": "1",
            "issn": "",
            "pages": "249-254",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF77": {
            "title": "Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis",
            "authors": [
                {
                    "first": "J.W.",
                    "middle": [],
                    "last": "Langston",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Ballard",
                    "suffix": ""
                },
                {
                    "first": "J.W.",
                    "middle": [],
                    "last": "Tetrud",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Irwin",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Science",
            "volume": "219",
            "issn": "",
            "pages": "979-980",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "van der Mark",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Brouwer",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Kromhout",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Nijssen",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Huss",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Vermeulen",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Environ Health Perspect",
            "volume": "120",
            "issn": "",
            "pages": "340-347",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF79": {
            "title": "Professional exposure to pesticides and Parkinson disease",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Elbaz",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Clavel",
                    "suffix": ""
                },
                {
                    "first": "P.J.",
                    "middle": [],
                    "last": "Rathouz",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Moisan",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Galanaud",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Delemotte",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Ann Neurol",
            "volume": "66",
            "issn": "",
            "pages": "494-504",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF80": {
            "title": "Rotenone, paraquat, and Parkinson's disease",
            "authors": [
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Tanner",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Kamel",
                    "suffix": ""
                },
                {
                    "first": "G.W.",
                    "middle": [],
                    "last": "Ross",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Hoppin",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Goldman",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Korell",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Environ Health Perspect",
            "volume": "119",
            "issn": "",
            "pages": "866-872",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF81": {
            "title": "Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice",
            "authors": [
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Pan-Montojo",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Schwarz",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Winkler",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Arnhold",
                    "suffix": ""
                },
                {
                    "first": "G.A.",
                    "middle": [],
                    "last": "O'Sullivan",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Pal",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Sci Rep",
            "volume": "2",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF82": {
            "title": "Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Braak",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "de Vos",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Bohl",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Del Tredici",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Neurosci Lett",
            "volume": "396",
            "issn": "",
            "pages": "67-72",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF83": {
            "title": "The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging",
            "authors": [
                {
                    "first": "M.E.",
                    "middle": [],
                    "last": "Kalaitzakis",
                    "suffix": ""
                },
                {
                    "first": "M.B.",
                    "middle": [],
                    "last": "Graeber",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Gentleman",
                    "suffix": ""
                },
                {
                    "first": "R.K.",
                    "middle": [],
                    "last": "Pearce",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Neuropathol Appl Neurobiol",
            "volume": "34",
            "issn": "",
            "pages": "284-295",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF84": {
            "title": "The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Attems",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Jellinger",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Neuropathol Appl Neurobiol",
            "volume": "34",
            "issn": "",
            "pages": "466-467",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF85": {
            "title": "The prion hypothesis in Parkinson's disease: braak to the future",
            "authors": [
                {
                    "first": "N.P.",
                    "middle": [],
                    "last": "Visanji",
                    "suffix": ""
                },
                {
                    "first": "P.L.",
                    "middle": [],
                    "last": "Brooks",
                    "suffix": ""
                },
                {
                    "first": "L.N.",
                    "middle": [],
                    "last": "Hazrati",
                    "suffix": ""
                },
                {
                    "first": "A.E.",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Acta Neuropathol Commun",
            "volume": "1",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF86": {
            "title": "Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations",
            "authors": [
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Dehay",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Bourdenx",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Gorry",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Przedborski",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Vila",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Hunot",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet Neurol",
            "volume": "14",
            "issn": "",
            "pages": "855-866",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF87": {
            "title": "Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Masliah",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Rockenstein",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Adame",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Alford",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Crews",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Hashimoto",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Neuron",
            "volume": "46",
            "issn": "",
            "pages": "857-868",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF88": {
            "title": "alpha-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model",
            "authors": [
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Sanchez-Guajardo",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Annibali",
                    "suffix": ""
                },
                {
                    "first": "P.H.",
                    "middle": [],
                    "last": "Jensen",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Romero-Ramos",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Neuropathol Exp Neurol",
            "volume": "72",
            "issn": "",
            "pages": "624-645",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF89": {
            "title": "Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Games",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Valera",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Spencer",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Rockenstein",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Mante",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Adame",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Neurosci",
            "volume": "34",
            "issn": "",
            "pages": "9441-9454",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF90": {
            "title": "Presymptomatic detection of prions in blood",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Saa",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Castilla",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Soto",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Science",
            "volume": "313",
            "issn": "",
            "pages": "92-94",
            "other_ids": {
                "DOI": []
            }
        }
    }
}